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Characterization of the RNA binding and RNA 
degrading subunits of the eukaryotic exosome 
 
Borislava B. Tsanova, B.S. 
Supervisory Professor, Ambro van Hoof, Ph.D. 
 
   The exosome is an essential complex of ten proteins involved in the processing 
and degradation of many RNAs in the cell. These include various stable RNAs, 
mRNAs, and aberrant transcripts both in the nucleus and in the cytoplasm. 
   In this work I characterize the three members of the exosome “cap”, the RNA 
binding proteins Rrp4, Rrp40, and Csl4. I determine that in spite of their structural 
similarity, they each have a unique essential role. Second, I determine that two of 
the cap proteins Rrp4 and Rrp40 have a role in bridging subunits of the PH ring of 
the exosome. The third cap protein Csl4 was shown not to have a bridging role.  
Further, I show that stable interaction with the exosome is not required for the 
essential role of Csl4.  
   In addition, I look at the physiological importance of the nuclease domains of the 
exosome. I show that the exonuclease is the primary activity for the exosome and 
that in its absence the iron starvation response of the cell is activated. 
   Despite numerous studies of the exosome, only a few address the physiological 
relevance of the catalytic activity. This work shows that the exonuclease of the 
exosome is important for oxidative stress protection and affects glucose metabolism 
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and provides a basis for future research into the physiological importance of this 
essential RNase. 
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Chapter 1: Introduction, background, and significance 
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INTRODUCTION AND BACKGROUND 
RNA degradation and processing 
   RNA degradation is used by all cells for applying temporal control of gene 
expression as well as maintaining its fidelity by eliminating aberrant transcripts. 
RNAs are degraded either at the end of the RNA life or if they are aberrant.  Such 
aberrant RNAs may result from genetic mutations, such as nonstop mutations or 
mistakes in processing the RNA, such as hypomodification of tRNAs. In each case, 
however, the persistence of the aberrant RNA will lead to errors in gene expression, 
thus the degradation serves a role as a surveillance mechanism to preserve the 
fidelity of gene expression.  
   The initial transcription of RNAs results in a primary RNA transcript. The primary 
RNA transcript is then processed and sometimes edited to produce the final mature 
RNA transcript. RNA processing refers to the addition or removal of components of 
the RNA. Processing reactions include shortening of the primary RNA transcript 
from either the 5’ or the 3’ end and in the case of mRNAs the addition of a 5’ 7-
methyl guanosine cap, addition of a 3’ poly(A) tail, and RNA splicing to remove 
introns (Lodish, 2000). 
   Often these two processes, RNA degradation and RNA processing are carried out 
by the same enzyme. However the recognition of a transcript intended for 
degradation from processing is thought to be accomplished by interaction with 
accessory proteins. Some proteins associate with the ribonuclease, in which case 
they are usually referred to as cofactors, while other proteins associate with the 
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RNA and form complexes called ribonucleoproteins (RNPs). It is believed that the 
combination of these factors and their interactions allows the cell to determine the 
fate of a particular transcript (Schilders et al., 2006).     
   Ribonucleases are classified as either endoribonucleases or exoribonucleases. 
Endoribonucleases cleave the phosphodiester bond within the RNA polynucleotide 
chain, while exoribonucleases cleave phosphodiester bonds at the end of the chain. 
The exonucleases can be further subcategorized into either 5’3’ exoribonucleases 
or 3’5’ exoribonucleases depending on the end from which they start degrading 
the RNA (from the 5’ end or from the 3’ end respectively; Arraiano et al., 2013). 
   Additionally, ribonucleases may not associate with protein complexes, such as the 
5’3’ exoribonuclease Xrn1, or they are assembled into larger protein complexes 
such as the major 3’5’ exoribonuclease, the exosome. 
 
The eukaryotic exosome 
   The major 3’5’ exoribonuclease in eukaryotes and archaea is the exosome 
(Chlebowski et al., 2013; Dziembowski et al., 2007). In eukaryotes, the exosome 
also has an endonuclease domain (Lebreton et al., 2008; Schaeffer et al., 2009; 
Schneider et al., 2009).  The eukaryotic exosomes that have been studied so far are 
well conserved through evolution (Chlebowski et al., 2013; Decker, 1998). The 
exosomes of Saccharomyces cerevisiae and the human exosome are very similar 
both in structure and in function (Sloan et al., 2012). They also include homologues 
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of the same protein subunits. This similarity makes S. cerevisiae a good model 
organism for studying the eukaryotic exosome. 
 
Structure of the exosome 
   The exosome is a complex of ten proteins, each of which is essential for life. 
There are several structures of eukaryotic exosomes including crystal structures of 
human and yeast exosomes (Liu et al., 2006; Makino et al., 2013) and EM 
reconstitutions of the exosome (Malet et al., 2010; Wang et al., 2007). Additionally, 
the catalytic subunit Rrp44 was independently crystallized with RNA and in a 
complex with Rrp41 and Rp45 (Bonneau et al., 2009; Lorentzen et al., 2008). 
   Based on the published structures listed above, nine of the ten proteins assemble 
in a cylindrical structure, composed of two rings, and the catalytic subunit is located 
on one side of this cylinder (Figure 1-1). The first ring is termed the exosome “cap” 
and it is composed of three RNA binding proteins, Rrp4, Rrp40, and Csl4. Each one 
of them has an S1 domain which is a known RNA binding domain originally 
identified in ribosomal protein S1. These S1 domains form a ring on the side of the 
exosome where RNA enters. The cap of the exosome is thought to mediate the 
initial interaction with the RNA substrate and/or interact with protein cofactors of the 
exosome; therefore it may be important in determining substrate specificity. 
   The middle portion of the exosome is composed of a larger ring called the PH 
ring, because of the RNase PH domains found in each of its component proteins. 
However, unlike RNase PH, the eukaryotic PH ring is inactive, lacking catalytic 
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activity. In archaea the PH ring is where catalysis occurs, but the active sites of 
eukaryotic exosomes have point mutations rendering them inactive (Dziembowski et 
al., 2007; Liu et al., 2006). The PH ring is composed of six proteins, Rrp41, Rrp42, 
Rrp43, Rrp45, Rrp46, and Mtr3. The 3’end of the RNA to be degraded is threaded 
through the PH ring as it emerges from the cap (the RNA binding ring) into the 
catalytic subunit Rrp44. 
   The tenth subunit, Rrp44, is located on the side where the RNA exits the ring 
(Wang et al., 2007).  It has an exonuclease domain which faces the RNA exit site of 
the exosome and an endonuclease domain which faces away from the PH ring 
cylinder (Malet et al., 2010).  Rrp44 is the only site of RNA degradation in the 
eukaryotic exosome. For detailed review on the structure and function of Rrp44 see 
Chapter 5.  
 
The RNA binding proteins of the exosome 
   Studies of individual eukaryotic RNA binding proteins are limited. For example, 
RNA binding affinity has been studied only in Rrp40 and the reports are conflicting 
with one study reporting no RNA binding while another showing RNA binding by 
Rrp40 (Luz et al., 2007; Oddone et al., 2007). Eukaryotic Csl4 has been studied 
specifically for its role in the cytoplasmic mRNA degradation by the exosome and a 
point mutation in its Zn ribbon-like domain (see chapter 4) was found to affect 
specifically 3’5’ mRNA degradation by the exosome (van Hoof et al., 2000b). 
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Figure 1-1. Structure of the exosome. Depiction of the structure of the 10 subunit 
eukaryotic exosome with RNA (in green). Locations of the exonuclease and the 
endonuclease within Rrp44 are show with asterisks (*).   
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   In archaea, the exosome has two RNA binding proteins, Rrp4 and Csl4 which are 
homologous to Rrp4 and Csl4 of S. cerevisiae respectively.  Archaeal Rrp4 is 
homologous to Rrp40 from eukaryotes, too. Archaea have several forms of the 
exosome, which differ by the stoichiometry of their RNA binding proteins while the 
PH ring remains the same. Exosomes with three Csl4 proteins, three Rrp4 proteins, 
or heterogeneous composition of the cap with mixed Rrp4 and Csl4 stoichiometry 
have been described (Buttner et al., 2005; Walter et al., 2006). The reason for this 
variability seems to be that, at least in archaea, the RNA binding proteins confer 
specificity to the exosome. This specificity is conferred in two ways. First, Rrp4 and 
Csl4 provide different substrate specificities to the exosome. Rrp4 exosomes prefer 
A-rich substrates while Csl4 exosomes prefer A-poor substrates (Roppelt et al., 
2010). Second, different exosome complexes interact with different cofactors. For 
example, DnaG only interacts with a Csl4 exosome, but not with an Rrp4 exosome 
(Hou et al., 2013). The binding of DnaG enhances the interaction of a Csl4 
exosome with A-rich substrates which are otherwise preferred by the Rrp4 
exosome. Even though there is high conservation of the RNA binding proteins it is 
unknown if their role in providing substrate specificity and/or protein interactions is 
also conserved in higher organisms. 
 
Catalytic activity of the exosome 
   Exosomes from all organisms have exoribonuclease activity. In archaea, the PH 
ring is the site of RNA degradation (Lorentzen et al., 2005). Eukaryotic exosome 
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have point mutations in the PH ring subunits, which render them catalytically 
inactive (Dziembowski et al., 2007; Liu et al., 2006). However, in eukaryotes there is 
a tenth subunit, Rrp44, which provides the catalytic activity of the exosome. More 
specifically, Rrp44 has processive hydrolytic 3’5’ exoribonuclease activity instead 
of the PH ring catalysis found in the archaeal exosome (Liu et al., 2006).  
Additionally, eukaryotes have evolved endoribonuclease activity, which is also 
found in Rrp44 but in a separate domain (Lebreton et al., 2008; Schaeffer et al., 
2009; Schneider et al., 2009).  
   Most eukaryotes have one Rrp44 subunit which harbors both the exonuclease 
and the endonuclease domains. Human cells have subfuncitonalized the 
ribonucleases of the exosome even further. This subfunctionalization involves both 
cellular compartmentalization as well as catalytic activity. There are three 
homologues of Rrp44 in humans: hDIS3, hDIS3L, and hDis3L2. hDIS3 is found 
predominantly in the nucleus of human cells, while hDIS3L and hDIS3L2 are strictly 
cytoplasmic. Only the nucleus- localized hDis3 has endonuclease activity, while the 
other two homologues have only exoribonuclease activity (Astuti et al., 2012; Staals 
et al., 2010; Tomecki et al., 2010).  In Schizosaccharomyces pombe, Dis3L2 does 
not associate with the exosome but still takes part in the cytoplasmic mRNA 
degradation pathway (Malecki et al., 2013). 
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Role of the exosome in the nucleus 
   The exosome was first discovered in S. cerevisiae as a nuclear ribosomal RNA 
processing machine required for the maturation of the 5.8S rRNA (Mitchell et al., 
1997). Specifically, it was discovered that in the nucleus the complex plays a role in 
the maturation of 5.8S rRNA and also of the degradation of the 5’ External 
transcribed spacer (ETS) of rRNA (de la Cruz et al., 1998). During the 5.8S rRNA 
maturation, the exosome degrades the 7S rRNA down to 5.8S + 30 nucleotides and 
then the final processing is dependent on Rrp6 (Allmang et al., 1999a). After the 
initial discovery, many studies have added various roles for the exosome making 
the exosome one of the most versatile cellular machines affecting most RNAs in the 
cell. 
   In addition to rRNA maturation, the exosome also takes part in the processing of 
snoRNAs, and snRNAs (Allmang et al., 1999a; van Hoof et al., 2000a).  The 3’ end 
of snRNAs U1, U4, and U5 are processed by the exosome. In this role the exosome 
functions together with Rrp6 by completing the final 3’ processing steps. The 
exosome degrades the initial 3’ nucleotides and then the final nucleotides are 
degraded in Rrp6-dependent manner.     
    snoRNAs can be independently transcribed or intron-derived. The exosome 
processes several snoRNAs together with its nuclear cofactor Rrp6, but not all 
snoRNAs require the exosome for 3’ maturation. As with the 5.8S rRNA and 
snRNAs, Rrp6 is only required for the final steps of snoRNA maturation, specifically 
the trimming of the last 3 nucleotides (Allmang et al., 1999a; van Hoof et al., 
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2000a). 
   In addition to processing, the exosome takes part in surveillance mechanisms, 
specifically the degradation of hypomodified tRNAMet , misprocessed rRNAs, cryptic 
unstable transcripts (CUTs), and the cotranscriptional surveillance of pre-mRNAs, 
(Andrulis et al., 2002; Kadaba et al., 2004; Thiebaut et al., 2006).     
   The essential role of the exosome is also believed to be in the nucleus. Deletion 
of the cytoplasmic cofactors of the exosome, which are required for all known 
cytoplasmic roles, is not lethal (Rhee et al., 1989; Sommer and Wickner, 1987; van 
Hoof et al., 2000b; Widner and Wickner, 1993). Additionally, some of the nuclear 
exosome cofactors are essential, specifically Mtr4 and all three components of the 
Nrd1/Nab3/Sen1 complex (Liang et al., 1996; Steinmetz and Brow, 1996; Wilson et 
al., 1994). It is not known what specific role of the exosome complex is essential 
because many of the nuclear roles of the exosome are potentially essential.   
   In the cytoplasm, the exosome takes part in the 3’5’ degradation of normal and 
aberrant mRNAs (see Normal mRNA degradation by the exosome in the cytoplasm 
in this chapter). In addition various exosome roles require different cofactors, thus it 
seems that the specificity of the degradation/processing targets is not determined 
by the exosome itself. 
 
Nuclear exosome cofactors 
   In the nucleus the exosome associates with Rrp6, an exonuclease homologous to 
RNase D from Escherichia coli. Rrp6 localizes to the nucleus in S. cerevisiae, but in 
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human cells and trypanosomes it has been found to be both in the nucleus and in 
the cytoplasm (Brouwer et al., 2001; Haile et al., 2007).  In vitro, Rrp6 forms a 
complex with the exosome of S. cerevisiae (Makino et al., 2013). Because Rrp6 
also interacts with the exosome in vivo, it is inferred that this complex forms in the 
cell’s nucleus (Allmang et al., 1999b). While Rrp6 functions together with the 
exosome in 5.8S rRNA maturation where it is required for the degradation of the last 
30 nucleotides (Briggs et al., 1998), and maturation of snRNAs and snoRNAs 
(Allmang et al., 1999a; van Hoof et al., 2000a), it also has exosome independent 
roles. For example, it degrades the last three nucleotides of some snoRNAs in an 
exosome independent manner (Allmang et al., 1999a; van Hoof et al., 2000a). Rrp6 
has also been found to be required independently of the exosome for cell 
proliferation and error-free mitosis in Drosophila melanogaster cells (Graham et al., 
2009b) 
   Additional nuclear cofactors of the exosome include Mtr4 and the TRAMP 
complex. Mtr4 is an RNA helicase which functions together with the exosome for its 
processing functions, specifically for processing of 5.8S rRNA, snoRNA, and 
snRNAs (Allmang et al., 1999a; de la Cruz et al., 1998; van Hoof et al., 2000a). For 
the degradation function of the exosome, Mtr4 is assembled in a complex, the 
TRAMP complex, with an RNA binding protein and a poly(A) polymerase, either 
Air1 or Air2 and either Trf4 or Trf5 respectively (Grzechnik and Kufel, 2008; LaCava 
et al., 2005; Rougemaille et al., 2007; Vanacova et al., 2005). Trf4 and Trf5 add 
short poly(A) tails to RNAs and these poly(A) tails are thought to promote 
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degradation by the exosome and it appears as each of them has different target 
RNAs (San Paolo et al., 2009).  
   Another complex with which the exosome is known to associate in the nucleus is 
the Nrd1/Nab3/Sen1 complex. Together with the exosome it functions in the 
processing of snRNAs and snoRNAs and degradation of misprocessed mRNAs and 
cryptic unstable transcripts (CUTS;Conrad et al., 2000; Thiebaut et al., 2006; 
Vasiljeva and Buratowski, 2006). Additionally the Nrd1/Nab3/Sen1 complex was 
shown to be involved, together with Rrp6 and the TRAMP complex, in the 3’ end 
processing of the CTH2 mRNA, which codes for a protein functioning in iron 
response (Ciais et al., 2008). Nrd1 and Nab3 have also been implicated in 
regulating the cellular response to nutrient availability (Darby et al., 2012)  
   As described, the exosome functions in processing or degradation of virtually all 
types of RNAs in the nucleus. For its various roles the exosome associates with 
many proteins and/or protein complexes. Most of these nuclear cofactors of the 
exosome have exosome-independent roles. Additionally, combinations of cofactors 
have been identified functioning together for some roles of the exosome. Such 
highly complex organization is indicative of the complicated nature of RNA 
recognition and degradation in the nucleus, of which the exosome is a major player.  
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Role of the exosome in the cytoplasm 
   In the cytoplasm the exosome plays a role in three general processes. First, it 
takes part in one of the two pathways for degradation of normal mRNAs. Second, it 
degrades aberrant mRNAs. Third, it has an antiviral role. For a depiction of normal 
an aberrant mRNA degradation see Figure 2. 
 
Cytoplasmic cofactors of the exosome 
   For all of its known cytoplasmic roles the exosome requires Ski7 and the Ski 
complex. The Ski complex is composed of Ski2, Ski3, and two copies of Ski8 and 
has been proposed to interact with the cap of the exosome through Ski7 (Halbach 
et al., 2013).  Ski7 is believed to function as a scaffold protein because it was found 
to interact with both the exosome and the Ski complex (Araki et al., 2001). A point 
mutation in Csl4, csl4G253E (published as ski4-1 ) that disturbs the exosome’s role 
in the cytoplasm also does not coimmunoprecipitate with Ski7 nor the Ski complex 
suggesting that the interaction with the Ski complex is required for the cytoplasmic 
exosome function (van Hoof et al., 2000b). 
 
Normal mRNA degradation by the exosome in the cytoplasm 
   In S. cerevisiae most mRNAs are deadenylated by the Ccr4-Not complex before 
being degraded (Decker and Parker, 1993; Tucker et al., 2002; Tucker et al., 2001). 
The deadenylation is a rate limiting step for the normal mRNA degradation. After 
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deadenylation, the mRNA can be degraded either from the 5’ end or from the 3’ end 
(Decker and Parker, 1993; Muhlrad et al., 1995). For a depiction of cytoplasmic 
mRNA degradation see Figure 1-2. When mRNAs are degraded from the 5’ end, 
the 7-methyl cap is removed by the decapping enzyme Dcp1/Dcp2 and then the 
mRNA is degraded by Xrn1 (Beelman et al., 1996; Dunckley and Parker, 1999; 
Muhlrad et al., 1994; Steiger et al., 2003). From the 3’ end mRNAs are degraded by 
the exosome, and the cap is then recycled by Dcs1 (Jacobs Anderson and Parker, 
1998; Liu et al., 2002; Wang and Kiledjian, 2001). These pathways function in a 
redundant manner because each of them is not essential on its own but blocking 
both is synthetic lethal (Jacobs Anderson and Parker, 1998). It is likely however that 
during normal cellular processes, both pathways take place simultaneously.  
Studies suggest that the 3’5’ pathway, which as stated above is the one in which 
the exosome is involved, is predominant in humans (Wang and Kiledjian, 2001), 
while the 5’3’ pathway is predominant in S. cerevisiae (Jacobs Anderson and 
Parker, 1998).  
 
Aberrant mRNA degradation by the exosome in the cytoplasm 
   The cytoplasmic exosome has been found to take part in mRNA surveillance for 
aberrant mRNAs, specifically mRNAs that lack a poly(A) tail or a stop codon (van 
Hoof et al., 2002).  
   The nonstop mRNA degradation pathway is conserved from yeast to humans and 
unlike regular mRNA degradation, it is deadenylation independent (Frischmeyer et 
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al., 2002). Because translation is required for nonstop mRNA decay and because 
ribosomes have been found to stall at the 3’ end of nonstop mRNAs, it is believed 
that the exosome is recruited to the nonstop mRNA after, at least, the first round of 
translation (Figure 1-2 B;  Ito-Harashima et al., 2007; van Hoof et al., 2002).  Ski7, 
as well as each of the Ski complex proteins, Ski2, Ski3, and Ski8, were also found 
to be required for nonstop mRNA decay (van Hoof et al., 2002).  Interestingly, the 
exoribonuclease and the endoribonuclease of the exosome were redundant for 
degrading nonstop mRNAs (Schaeffer and van Hoof, 2011).  
   Because there are no stop codons, the 3’ UTR and the poly(A) tail would also be 
translated resulting in a poly(lysine) tag for the aberrant protein which in turn would 
be targeted for degradation by the 26S proteasome. A genetic screen for 
suppressors of nonstop mRNA decay identified several mutations involving the 
proteasome, thus supporting this model (Wilson et al., 2007).  
 
Antiviral role of the exosome 
   The cytoplasmic exosome also has antiviral role. S. cerevisiae commonly contains 
an endogenous L-A virus. Additionally, some strains contain M satellite RNA which 
codes for a toxin (killer toxin) that is secreted from the cell and kills neighboring cells 
that are not infected. The expression of the M satellite is dependent on RNA-
dependent RNA polymerase which is encoded by the L-A virus (Wickner et al., 
1991). The cytoplasmic exosome is implicated in surveillance of the M satellite 
because all of the ski mutants were identified in S. cerevisiae in a screen for  
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Figure 1-2. Cytoplasmic mRNA degradation by the exosome.  A. The exosome in the 
normal mRNA degradation pathway. This pathway is deadenylation dependent. mRNAs are 
first deadenylated by the Ccr4-Not complex and then degraded either 5’3’ by Xrn1 (after 
decapping by Dcp2, not shown here) or 3’5’ by the exosome. Ski = ski complex. B. 
Degradation of aberrant mRNAs by the exosome as exemplified by a nonstop mRNA. 
Deadenylation is not needed and these mRNAs are degraded directly by the exosome 
which is facilitated by the ski complex and Ski7. 
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increased secretion of the killer toxin (Ridley et al., 1984; Toh et al., 1978). Two of 
the proteins, Ski4 and Ski6, later were determined to be the exosome components 
Csl4 and Rrp41 respectively (Mitchell et al., 1997; van Hoof et al., 2000b) and 
several of these encode cytoplasmic cofactors of the exosome such as Ski7 and the 
Ski complex proteins Ski2, Ski3, and Ski8 (Brown et al., 2000). The exact 
mechanism of   exosome involvement is not known, but it seems that the secretion 
of the killer toxin is affected by lowering the viral RNA levels presumably by 
degrading it.   
 
SIGNIFICANCE OF THIS STUDY 
 
Exosome-dependent processing and degradation of RNAs affects virtually all 
cellular processes 
   Degradation of RNA is an essential process, important for normal cellular function 
at many levels. RNA surveillance, maturation and gene expression control involve 
RNA degradation. Therefore, it is of high importance that the processes by which 
RNA is degraded are understood. Fundamental understanding of these processes 
includes both the basic task of characterizing the proteins that make up the RNA 
degrading complexes as well as understanding the global effect these RNase 
enzymes have on gene expression.  
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   This study characterizes the cap proteins of the exosome, which is the major 
3’5’ exoribonuclease in eukaryotes and archaea. These three proteins are at the 
site of RNA entry and have several RNA binding domains. This study shows that 
not only do they have a functional role in the exosome, but they likely also have a 
structural role. It adds to our understanding of how the complex is held together and 
gives us a possible explanation of why three so similar proteins have unique roles.  
   Further, this research addresses the global effect of the exonuclease on the cell. It 
shows that the ultimate effect on gene expression is not as extensive as would be 
expected from the number and variety of substrates of the exosome. Identifying the 
major cellular processes that are affected by the exosome is significant because it 
adds to our understanding of global exosome regulation as well as opens the way to 
new research in the area of functional relevance in addition to the more technical 
study of individual substrates. 
 
Importance to translational research 
   The exosome is important in human related research for four general reasons. 
First, mutations of exosome components themselves cause disease in humans. 
Specifically related to this study, mutations in Rrp40 cause severe neurological 
problems in infants (Wan et al., 2012). For detailed description of Rrp40 mutations 
related to health see Chapter 3.  In addition, a mutation in two of the cytoplasmic 
co-factors of the exosome, Ski2 and Ski3, cause Syndromic diarrhea, a GI disorder 
(Fabre et al., 2012). Finally, mutations in one of the human homologues of Rrp44, 
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Dis3L2 cause Perlman syndrome which is a genetic disorder characterized by 
susceptibility to a childhood associated nephroblastoma (Astuti et al., 2012). 
Second, mutations that target the mutated transcript to the exosome, such as 
nonstop mutations, cause disease in humans such as hemorrhages, muscular 
dystrophy and Diamond-Blackfan anemia  (Ameri et al., 2007; Cacciottolo et al., 
2011; Klauer and van Hoof, 2012; Willig et al., 1999). Third, the exosome is a target 
of the immune system in the case of the autoimmune disease 
polymyocitis/scleroderma (Allmang et al., 1999b). Fourth, the exosome’s activity is 
also targeted for cancer treatment by the drug 5FU (Fang et al., 2004; Silverstein et 
al., 2011). 
   The exosome has antiviral role in S. cerevisiae. Because it is such a conserved 
and versatile RNase it is also possible that it has antiviral role in human cells. 
Therefore a study of the east exosome’s activity will be beneficial for future work in 
understanding how cells detect and neutralize infection by RNA viruses.  
   Understanding how the exosome works, may help develop new therapeutic 
options for people that have exosome-related diseases. Moreover, because the 
exosome structure and function are so well conserved from yeast to human, S. 
cerevisiae is a well-suited model organism for its study. The knowledge gained from 
the S. cerevisiae exosome may benefit the research when applied to the human 
organism.  
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Chapter 2: Materials and methods 
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Yeast strains, media and growth conditions 
Strains 
   All yeast strains used in this study are haploid and are listed in Table 2-1.  
 
Media 
   All of the S. cerevisiae strains used in this work were grown, unless otherwise 
specified, in YPD (yeast peptone dextrose) medium composed of 1% yeast extract, 
2% peptone, 2% dextrose or in synthetic complete (SC) drop-out powder obtained 
from Sunrise Science Products, lacking the specified nutrient for plasmid selection. 
YPD medium with 5.74 mM of 5-fluoroorotic acid (5FOA) was used to select for 
strains that have lost a plasmid with a URA3 marker for plasmid shuffle assay (see 
below).  
 
Growth conditions 
   Unless otherwise noted all cultures were started overnight in 5 ml  YPD and then 
transferred the next morning to the specified medium and grown at 30oC.  
   For assays requiring RNA or protein isolation, cell cultures were grown to 
OD600=0.6, centrifuged, the supernatant was removed and the cells were washed 
with H2O, collected and frozen at -80
oC.  
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Table 2-1 Strains used 
Strain 
name 
Genotype Reference 
yAV1104 MATa; leu2-0; lys2-0; ura3-0; his3-1; rrp4::NEO 
[RRP4, URA3] 
(Schaeffer et al., 2009) 
yAV1107 MATa; leu2-0; LYS2; MET15; ura3-0; his3-1; 
rrp40::NEO [RRP40, URA3] 
(Schaeffer et al., 2009) 
yAV1047 MATa; leu2-0; LYS2; met150; ura3; his3-1; 
csl4::NEO [CSL4, URA3] 
(Schaeffer et al., 2009) 
yAV40 MAT; trp1-; leu2-3; lys2-201; ura3-52; HIS4; CUP1; rrp4-
1; ade1-100  
This study 
yAV245 MATa; trp1; LEU2; lys2; ura3-52; HIS4; CUP1; mtr14-1, 
ade1; aro-; HIS3; HIS1 
T2639 from A. Tartakoff 
yAV229 MATa; TRP1; leu2-3; LYS2; ura3-52; his4-519; CUP1; 
ade1-100; rrp4::GAL10-protA-RRP4 
(Mitchell et al., 1997) 
yAV253 MATa; trp1; leu21; LYS2; ura3-52; HIS4; CUP1; 
GAL::rrp40; his3200; gal2; gal108 
(Mitchell et al., 1997) 
yAV255 MATa; trp1;  leu2-1; LYS2; ura3; HIS4; CUP1; GAL::csl4; 
his3200; gal2; gal108 
(Mitchell et al., 1997) 
yAV1128 leu2-0; ura3-0;  his3-1; rrp4::HYG; rro40::NEO; 
MET15 [RRP4, URA3] [RRP40, URA3] 
This study 
yAV340 MATa; trp1; leu2; lys2; ura3; HIS4; CUP1::LEU2PM; dcp1-
2:;TRP1; ski4-1 
(van Hoof et al., 2000b) 
yAV1117 MATa, his31, leu20, ura30, met150, RRP43-
myc::HIS3 
(Schaeffer et al., 2009) 
yAV1129 MAT; leu2-0; ura3-0; his3-1; rrp44::NEO [RRP44, 
LEU2] 
This study 
yAV1131 MAT; leu2-0; ura3-0; his3-1; rrp44::NEO [RRP44 
D551N, LEU2] 
This study 
yAV1284 MATa; TRP1; leu2-; lys2; ura3-; HIS4; CUP1; his3; 
rrp44::NAT [RRP44, LEU2] 
This study 
yAV1135 MAT; leu2-0; ura3-0; his3-1; rrp44::NEO [RRP44 
D171A, LEU2] 
This study 
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Oxidative stress media 
   Oxidative stress was achieved by adding 2.0H2O2 or 50of menadione to 
the medium in which the strain were grown. Both liquid and solid media were 
supplemented with the same concentrations. For some experiments 1.0H2O2 
was used, because rrp44-exo- stopped growing at 2.0H2O2. 
 
Iron supplementation and depletion 
   When iron was added to medium, it was added as 100FAS (ferrous 
ammonium sulfate). To chelate iron, 100of the iron chelator 
bathophenanthroline disulfonate (BPS) was added to the medium. 
 
Respiratory growth media 
   YEP + 2% glycerol or YEP + 2% ethanol media were used to stimulate respiratory 
growth conditions. 
 
Yeast transformation  
   Transformation was done as described (Schiestl and Gietz, 1989). Briefly, yeast 
cells were incubated with 1g of plasmid in 300 L of PLATE (40%v/v PEG3350, 
0.1M LiAc, 10 mM TrisHcl, 1 mM EDTA) solution and 10L heat denatured ssDNA. 
Incubation was done at room temperature overnight. Then the cells were 
centrifuged, the PLATE solution removed and the yeast cells were plated on 
selective medium. 
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Table 2-2. Plasmids used  
Name Description Marker Vector 
backbone 
Insert : origin  Vector: origin 
pAV188 His3 nonstop reporter URA3 CEN (van Hoof et al., 2002) 
pAV302 Csl4 3’ UTR LEU2 CEN PCR with oAV366 and 
oAV118 
  
pRS415 
pAV303 Csl4 1-126 LEU2 CEN PCR with oAV365 and 
oAV372 
pAV302 
pAV304 Csl4 1-251 LEU2 CEN PCR with oAV365 and 
oAV371 
pAV302 
pAV305 Csl4 LEU2 CEN PCR with oAV365 and 
oAV370  
 
pAV302 
pAV335 Csl4 111-292 LEU2 CEN PCR with oAV405 and 
oAV370 
  
pAV305 
 
pAV421 Rrp4 3'UTR in pRS415 LEU2 CEN PCR with oAV424 & 
oAV425 
pRS415 
pAV425 Rrp4 full length LEU2 CEN PCR with oAV426 & 
oAV429 
pAV421 
pAV441 Rrp4 1-105 LEU2 CEN PCR with oAV426 & 
oAV500 
pAV421 
pAV442 Rrp4 1-190  LEU2 CEN PCR with oAV426 and 
oAV501 
pAV421 
pAV443 Rrp4 URA3 CEN Digest of pAV426 with 
XbaI and XhoI 
pRS416 
pAV444 Gal_Csl4 in pRS425 LEU2 2 pAV345 digestion with 
PvuII 
pRS425 
pAV445 Gal_Rrp4 in pRS425 LEU2 2 pAV346 digestion with 
PvuII 
pRS425 
pAV446 Gal_Rrp40 in pRS425 LEU2 2 pAV 347 digestion with 
PvuII 
pRS425 
pAV447 Rrp40 1-65  URA3 CEN PCR of Rrp40 ( 1-65) 
with oAV 432 and 
oAV506 
pRS436 
pAV448 Rrp40 1-140  URA3 CEN PCR of Rrp40 ( 1-140) 
with oAV432 and 
oAV507 
pAV436 
pAV449 Rrp40 URA3 CEN PCR of Rrp40 ( 1-240) 
with oAV 432 and 
oAV508 
pAV436 
pAV459 Rrp40 1-65  LEU2 CEN pAV447 digestion with 
XbaI and HindIII 
pRS415 
pAV460 Rrp40 1-140  LEU2 CEN pAV448 digestion pRS415 
pAV461 Rrp40 LEU2 CEN pAV449 - digestion pS415 
pAV466 Rrp40 65-240 LEU2 CEN PCR with oAV531 and 
oAV431 
pAV465 
pAV467 Rrp40 140-240  LEU2 CEN PCR with oAV532 and 
oAV431 
pAV465 
pAV469 Rrp40 65-240 URA3 CEN pAV466 pRS416 
pAV470 Rrp40 140 -240 URA3 CEN pAV467 pRS416 
pAV471 Rrp4 105-359  LEU2 CEN PCR with oAV528 and 
oAV425 
pAV464 
pAV472 Rrp4 190 -359  LEU2 CEN PCR with oAV529 and 
oAV425 
pAV464 
pAV476 TAP tag 
 
LEU2 CEN PCR with oAV556 and 
oAV557 
pRS415 
pAV477 5' UTR of Rrp 4 + 3' 
TAP tag 
LEU2 CEN PCR with oAV556 and 
oAV557 
pAV464 
pAV478 5' UTR of Rrp 40 + 3' 
TAP tag 
 
 
LEU2 CEN PCR with oAV556 and 
oAV557 
 
 
pAV464 
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Table 2-2. Plasmids used (continued) 
Name Description Marker Vector 
backbone 
Insert : origin  Vector: origin 
pAV487 Rrp4 1-105-TAP  LEU2 CEN PCR with oAV533 and 
oAV558 
pAV476 
pAV488 Rrp4 1-190-TAP LEU2 CEN PCR with oAV533 and 
oAV559 
pAV476 
pAV489 Rrp4 105-359-TAP  LEU2 CEN PCR with oAV528 and  
oAV560 
pAV477 
pAV490 Rrp4 190-359-TAP  LEU2 CEN PCR with oAV529 and 
oAV560 
pAV477 
pAV491 Rrp4-TAP LEU2 CEN PCR with oAV533 and 
oAV560 
pAV476 
pAV492 Rrp40 1-65-TAP LEU2 CEN PCR with oAV534 and 
oAV561 
pAV476 
pAV493 Rrp40 1-140-TAP LEU2 CEN PCR with oAV534  and 
oAV562 
pAV476 
pAV494 Rrp40 65-240-TAP LEU2 CEN PCR with oAV531 and 
oAV563 
pAV478 
pAV495 Rrp40 140-240-TAP LEU2 CEN PCR with oAV532 and 
oAV563 
pAV478 
pAV496 Rrp40-TAP LEU2 CEN PCR with oAV534 and 
oAV563 
pAV476 
pAV532 Rrp4 S152A  LEU2 CEN Mutagenesis with 
oAV595 and oAV596 
pAV426 
pAV533 Rrp4 S152E LEU2 CEN Mutagenesis with 
oAV597 and oAV598 
pAV426 
pAV534 Csl4 S94A LEU2 CEN Mutagenesis with 
oAV599 and oAV600 
pAV305 
pAV535 Csl4 S94E LEU2 CEN Mutagenesis with 
oAV601 and oAV602 
pAV305 
pAV541 Rrp4 1-105 HIS3 CEN Digestion of pAV441 pRS413 
pAV542 Rrp4 1-190 HIS3 CEN Digestion of pAV442 pRS413 
pAV543 Rrp4-TAP URA3 CEN Digestion of pAV491 
with SacI and XhoI 
pRS416 
pAV544 Csl4 W272A LEU2 CEN Mutagenesis with 
oAV617 and oAV618 
pAV305 
pAV545 Csl4Y268A,T270A,W2
72A 
LEU2 CEN Mutagenesis with 
oAV619 and oAV620 
pAV305 
pAV550 Rrp4 1-105 + Rrp40 
65-240 Chimera 
LEU2 CEN PCR from pAV461 with 
oAV607 and oAV609 
pAV487 
pAV551 Rrp4 1-190 + Rrp40 
140-240 Chimera 
LEU2 CEN PCR from pAV461 with 
oAV608 and oAV609 
pAV488 
pAV552 Rrp40 1-65+ Rrp4 105-
359 Chimera 
LEU2 CEN PCR from pAV426 with 
oAV604 and oAV606 
pAV492 
pAV553 Rrp40 1-140 + Rrp4 
190-359 Chimera 
LEU2 CEN PCR from pAV426 with 
oAV605 and oAV606 
pAV493 
pAV554 Csl4 - V210A, R211A LEU2 CEN Mutagenesis with 
oAV629 and oAV630 
pAV305 
pAV555 Csl4 - D214A, R215A LEU2 CEN Mutagenesis with 
oAV631 and oAV632 
pAV305 
pAV556 Csl4 - D216A, R217A LEU2 CEN Mutagenesis with 
oAV633 and oAV634 
pAV305 
pAV557 Csl4 - S236A, L237A LEU2 CEN Mutagenesis with 
oAV635 and oAV636 
pAV305 
pAV558 Csl4 110-292  W272A LEU2 CEN Mutagenesis  with 
oAV617 andoAV618 
pAV 335 
pAV559 Csl4 110-292  
Y268A,T270A,W272A 
LEU2 CEN Mutagenesis with 
oAV619 andoAV620 
pAV335 
pAV560 Csl4 110-292 V210A, 
R211A 
LEU2 CEN Mutagenesis with 
oAV629 and oAV630 
pAV 335 
pAV561 Csl4 110-292 D214A, 
R215A 
 
 
LEU2 CEN Mutagenesis with 
oAV631 and oAV632 
pAV335 
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Table 2-2. Plasmids used (continued) 
Name Description Marker Vector 
backbone 
Insert : origin  Vector: origin 
pAV562 Csl4 110-292  D216A, 
R217A 
LEU2 CEN Mutagenesis with 
oAV633 and oAV634 
 
pAV335 
pAV563  Csl4 110-292 S236A, 
L237A 
LEU2 CEN Mutagenesis with 
oAV635 and oAV636 
pAV335 
pAV569 Csl4 110-250  LEU2 CEN PCR of pAV305 with 
oAV405(SphI) and 
oAV371(BamHI) 
pAV305 
pAV582 Csl4 S1(110-250) - 
TAP 
LEU2 CEN PCR from pAV569 with 
oAV365 and oAV669 
pAV476 
pAV583 Csl4 Zn(248-291) - 
TAP 
LEU2 CEN PCR from pAV336 with 
oAV365 and oAV661 
pAV476 
pAV584 Csl4-TAP LEU2 CEN PCR from pAV305 with 
oAV365 and oAV661 
pAV476 
pAV640 Rrp40 1-65+ Rrp4 105-
359 
HIS3 CEN Digestion  of pAV552 pR413 
pAV641 Rrp40 1-140 + Rrp4 
190-359 Chimera 
HIS3 CEN Digestion  of pAV553 pRS413 
pAV642 Rrp40 (1-65)+Rrp4 
(105-190) + Rrp40 
(140-240) Chimera 
HIS3 CEN Digestion  of pAV565 pRS413 
pAV643 Rrp40 HIS3 CEN Digestion of pAV461 pRS413 
pAV646 Csl4 1-126-TAP LEU2 CEN PCR from pAV305 with 
oAV365 and oAV699 
pAV476 
pAV647 Csl4 1-250-TAP LEU2 CEN PCR from pAV305 with 
oAV365 and oAV668 
pAV476 
pAV648 Csl4 111-292-TAP LEU2 CEN PCR from pAV305 with 
oAV365 and oAV61 
pAV476 
pAV649 Csl4 111-292  D251A, 
L252A 
LEU2 CEN Mutagenesis with 
oAV700 and oAV701 
pAV335 
pAV650 Csl4 111-292 G253A LEU2 CEN Mutagenesis with 
oAV702 and oAV703 
pAV335 
pAV651 Csl4 111-292 
V254A,V255A 
LEU2 CEN Mutagenesis with 
oAV704 and oAV705 
pAV335 
pAV652 Csl4 111-292 M267A LEU2 CEN Mutagenesis with 
oAV706 and oAV707 
pAV335 
pAV653 Csl4 111-292 M275A, 
P278A 
LEU2 CEN Mutagenesis with 
oAV708 and oAV709 
pAV335 
pAV654 Csl4 111-292 E284A, 
R286A, K287A 
LEU2 CEN Mutagenesis with 
oAV710 and oAV711 
pAV335 
pAV655 Csl4 111-292 K290A LEU2 CEN Mutagenesis with 
oAV712 and oAV713 
pAV335 
pAV666 Csl4 1-126-FLAG LEU2 CEN PCR of pAV303 with 
oAV365(XbaI) and 
oAV723(BamHI) 
pAV302 
pAV667 Csl4 1-251-FLAG LEU2 CEN PCR of pAV304 with 
oAV365(XbaI) and 
oAV724(BamHI) 
pAV302 
pAV668 Csl4 111-292-FLAG LEU2 CEN PCR of pAV335 with 
oAV365(XbaI) and 
oAV725(BamHI) 
pAV302 
pAV669 Csl4 247-292-FLAG LEU2 CEN PCR of pAV336 with 
oAV365(XbaI) and 
oAV725(BamHI) 
pAV302 
pAV670 Csl4-FLAG LEU2 CEN PCR of pAV305 with 
oAV365(XbaI) and 
oAV725(BamHI) 
pAV302 
pAV679 Csl4 1-126 S94E LEU2 CEN Mutagenesis of pAV666 
with oAV601 and 
oAV602 
pAV666 
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Table 2-2. Plasmids used (continued) 
pAV680 Csl4 111-292-TAP 
V210A,R211A 
LEU2 CEN Mutagenesis of pAV648  
with oAV629 and 
oAV630 
pAV648 
pAV681 Csl4 111-292-TAP 
D214A, R215A 
LEU2 CEN Mutagenesis of pAV648  
with oAV631 and 
oAV632 
pAV648 
pAV682 Csl4 111-292_TAP 
D216A, R217A 
LEU2 CEN Mutagenesis of pAV648  
with oAV633 and 
oAV634 
pAV648 
pAV683 Csl4 111-292-TAP 
S236A, L237A 
LEU2 CEN Mutagenesis of pAV648  
with oAV635 and 
oAV636 
pAV648 
pAV684 Csl4 111-292-TAP 
D251A, L252A 
LEU2 CEN Mutagenesis of pAV648  
with oAV700 and 
oAV701 
pAV648 
pAV685 Csl4 111-292-TAP 
G253A 
LEU2 CEN Mutagenesis of pAV648  
with oAV702 and 
oAV703 
pAV648 
pAV686 Csl4 111-292-TAP 
V254A, V255A 
LEU2 CEN Mutagenesis of pAV648  
with oAV704 and 
oAV705 
pAV648 
pAV687 Csl4 111-292-TAP 
M267A 
LEU2 CEN Mutagenesis of pAV648  
with oAV706 and 
oAV707 
pAV648 
pAV688 Csl4 111-292-TAP 
Y268A,T270A,W272A 
LEU2 CEN Mutagenesis of pAV648  
with oAV619 and 
oAV620 
pAV648 
pAV689 Csl4 111-292-TAP 
Y268A 
LEU2 CEN Mutagenesis of pAV648  
with oAV657 and 
oAV658 
pAV648 
pAV690 Csl4 111-292-TAP 
T270A 
LEU2 CEN Mutagenesis of pAV648  
with oAV659 and 
oAV660 
pAV648 
pAV691 Csl4 111-292-TAP 
W272A 
LEU2 CEN Mutagenesis of pAV648  
with oAV617 and 
oAV618 
pAV648 
pAV692 Csl4 111-292-TAP 
M275A, P278A 
LEU2 CEN Mutagenesis of pAV648  
with oAV708 and 
oAV709 
pAV648 
pAV693 Csl4 111-292-TAP 
E284A, R286A, K287A 
LEU2 CEN Mutagenesis of pAV648  
with oAV710 and 
oAV711 
pAV648 
pAV694 Csl4 111-292-TAP 
K290A 
LEU2 CEN Mutagenesis of pAV648  
with oAV712 and 
oAV713 
pAV648 
pAV786  cyc1_LacZ  URA3 2 (Marx and Lidstrom, 2001) 
 
pAV804 cyc1_aft1BS_LacZ URA3 2 Oligonucleotides cloning 
with oAV886 and oAV88 
pAV786 
pAV843 Aft1-GFP URA3   2  (Crisp et al., 2003)   
pRS413 empty vector HIS3 CEN (Mumberg et al., 1995) 
   
pRS415 empty vector LEU2 CEN 
pRS416 empty vector URA3 CEN 
pRS425 empty vector LEU2 2 
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Plasmids used in this study 
   Plasmids used in this study are listed in Table 2-2. All plasmids, unless otherwise 
noted, have an endogenous promoter and 3’ UTR to ensure expression at normal 
endogenous level. Additionally each plasmid has a marker for selection. The 
markers used in this work were URA3, LEU2, or HIS3. 
 
C-terminal TAP tag cloning 
   All of the proteins that were tagged with a TAP tag were tagged at their C-
terminus by removing the stop codon of the sequence to be tagged and adding a G 
followed by a PstI site (G CTGCAG). That positions the TAP tag in frame and 
results in adding 2 alanine residues and a glycine residue between the tagged 
protein and the TAP tag. For a depiction of the TAP-tagging see Figure 2.1.  
 
Site-directed mutagenesis 
   Site directed mutagenesis was performed using Quick Change Protocol 
(Stratagene) with the indicated PCR primers and PfuUltra DNA polymerase 
(Stratagene). PCR settings were as suggested by the manufacturer as follows: 
initial denaturation - 95oC for 30 seconds; 18 cycles of: 95oC for 30 seconds, 55oC 
for 1 minute, 68oC – for 1 min per kb of plasmid; one addition cycle of 68oC for 1 
min per kB of plasmid length. The PCR was then treated with 1l DpnI (NEB) for 1 
hour at 37oC. 2 l of the DpnI treated reaction were transformed in chemically 
competent E. coli cells, plated on LB+0.5 mg/ml Ampicillin, and grown at 37oC 
overnight. Colonies were then picked, grown on LB + Amp and screened by 
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restriction digestion (each primer has a restriction site that does not change the 
protein coding sequence for screening) and then the sequence was confirmed by 
DNA sequencing. 
 
Growth assays 
   Liquid growth assays were started with yeast cells at OD600=0.1 from an overnight 
culture in YPD, or required selective medium, at 30oC.  
   Plate growth assays were done as follows. 5x serial dilutions, starting with 
OD600=0.6 were done in a 96-well plate and then were spotted on selective plates 
and grown at the indicated temperature. Unless otherwise indicated, all pictures 
were taken either on day 3 or on day 4 after plating.  
 
Plasmid shuffle assay 
   The purpose of this assay is to replace an essential protein with a mutant version 
of the same protein. A haploid yeast strain with a knock out of the particular gene in 
the genome and a plasmid encoded wild-type version with a URA3 marker was 
transformed with a mutant gene on a plasmid with the LEU2 marker. Transformants 
were selected on SC-Leu-Ura medium, and then growth assays, as described, were 
performed on 5FOA. 5FOA selects for cells that have lost the URA3 marker 
effectively shuffling the LEU2 vector for the URA3 vector (Boeke et al., 1984). 
Growth on 5FOA indicates that the LEU2 born mutant can substitute for the 
essential role of the wild-type gene.  
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Table 2-3. Primers used 
Name Sequence 
oAV365 CGCGATCTAGAGGAATTCGAATATGATAGACATCC 
oAV366 GGTATCGATAAGCTTCGGTGGTATTGTAGG 
oAV370 CGCGAGGATCCTTAAAAAGGTTTGGCACATTTGCGCTT 
oAV371 CGCGAGGATCCTTAGTCATTCCTTGCAGTGGTCAAA 
oAV372 CGCGAGGATCCTTAATTAGCATATTTGTTGGTTTTACGAC 
oAV405 CGCTGGCATGCCTTCCTGGGACAGAAAAGGGTCGTAAAACC 
oAV424 CGCGAGGATCCCAAAAGCCGCTGTTTACACATTTATAAAC 
oAV425 CGCGACTCGAGCTGCTACCTTTGCCAGTGGTAAACC 
oAV426 CGCGATCTAGAGGAATACTGGCAGTGCGATTTTCATGC 
oAV429 CGCGAGGATCCTATTAGTTGCCGTTACCTCTCA 
oAV430 CGCGAGGATCCATGGTATAATTAAAATATATAAACACATAGAT 
oAV431 CGCGAAGCTTCGTATTAGATATGTGCACTATAGTTGTCG 
oAV432 CGCGATCTAGAGCGTTATACTGCGTTATACTGCG 
oAV500 CGCGAGGATCCTATTAGGCATAACGACCTTTCAATGGAATTACCG 
oAV501 CGCGAGGATCCTATTACTTTAGAGACCTTGTATGTAAAGAGGC 
oAV506 CGCGAGGATCCTAGTTTAAATGTATCTCTTACTAGAATAGTCT 
oAV507 CGCGAGGATCCTAGTTTAAGTTGAGTCAAAACATTCTATTTCGGC 
oAV508 CGCGAGGATCCTAGTTTACTCCTCCTTGACCGTAAGTAT 
oAV527 CGCGATCTAGACGCTTGTGTGACTACGCAAAGATTTAG 
oAV528 CGCGATCTAGAAACAGATATGGCCCCAGAAACTGGTGATCACGTCGTAGGG 
oAV529 CGCGATCTAGAAACAGATATGAAGTACGGGAAGTTAAGAAACGGG 
oAV530 CGCGATCTAGACTCTTGGTTAGTCGAAATGCTGG 
oAV531 CGCGATCTAGACATACAAGATGATTCCATCTGTAAACGATTTTGTAATCG 
oAV532 CGCGATCTAGACATACAAGATGACTACAGGACGCGATGCTGGTTTCGG 
oAV533 CGCGAGAGCTCGGAATACTGGCAGTGCGATTTT 
oAV534 CGCGAGAGCTCGCGTTATACTGCGTTATACTG 
oAV556 CGCCTGCAGGTCGACGGATCCCCGGGTTAATTAATCCA 
oAV557 CGCAAGCTTTGCCGGTAGAGGTGTGGTCAATAAGAGCGAC 
oAV558 CGCCTGCAGCGGCATAACGACCTTTCAATGGAATTACCGATAGCA 
oAV559 CGCCTGCAGCCTTTAGAGACCTTGTATGTAAAGAGGCACT 
oAV560 CGCCTGCAGCGTTGCCGTTACCTCTCATTTTTTCGGCGGT 
oAV561 CGCCTGCAGCAATGTATCTCTTACTAGAATAGTCTATATA 
oAV562 CGCCTGCAGCAGTTGAGTCAAAACATTCTATTTCGGCTTC 
oAV563 CGCCTGCAGCCTCCTCCTTGACCGTAAGTATTTCTTTAAA 
oAV595 CCGGGTGGAATTCTAAGAAGAAAAGCTGAAAGTG 
oAV596 CACTTTCCTCTTTTCTTCTTAGAATTCCACCCGG 
oAV597 CCGGGTGGAATTCTAAGAAGAAAAGAGGAAAGTG 
 
oAV598 CACTTTCAGCTTTTCTTCTTAGAATTCCACCCGG 
oAV599 GGAAGAAAAATCAGTCGACGCAGCACCTAATGATGTCACAAG 
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Table 2-3. Primers used (continued) 
Name Sequence 
oAV600 CTTGTGACATCATTAGGTGCTGCGTCGACTGATTTTTCTTCC 
oAV601 GGAAGAAAAATCAGTCGACGCAGAACCTAATGATGTCACAAG 
oAV602 CTTGTGACATCATTAGGTTCTGCGTCGACTGATTTTTCTTCC 
oAV604 CGCGACTGCAGCTGCCCCAGAAACTGGTGATCACGTCGTAGG 
oAV605 CGCGACTGCAGCTAAGTACGGGAAGTTAAGAAACGGGATG 
oAV606 CGCGACTCGAGCTGCTACCTTTGCCAGTGGTAAACC 
oAV607 CGCGACTGCAGCTATTCCATCTGTAAACGATTTTGTAATCGG 
oAV608 CGCGACTGCAGCTACTACAGGACGCGATGCTGGTTTCGG 
oAV609 CGCGCTCGAGCGTATTAGATATGTGCACTATAGTTGTCG 
oAV612 CGCGAGGGCCCGCCACCATGTCCGAAGTTATCACAATTACCAAGCGG 
oAV613 CGCGAGGGCCCGCCACCATGTCTACGTTCATATTCCCTGGTGATAGC 
oAV614 CGCGAGGGCCCGCCACCATGGCATGCAATTTTCAGTTTCCAGAAATAGC 
oAV617 GGTGGATTAATGTATGCTACAGACGCGCAAATGATGACTTCACCG 
oAV618 CGGTGAAGTCATCATTTGCGCGTCTGTAGCATACATTAATCCACC 
oAV619 GGTGGATTAATGGCTGCTGCAGACGCGCAAATGATGACTTCACCG 
oAV620 CGGTGAAGTCATCATTTGCGCGTCTGCAGCAGCCATTAATCCACC 
oAV621 CGCGACTCGAGGCCACCATGTCTACGTTCATATTCCCTGGTGATAGC 
oAV629 GGTATAATCCGATCGCAGGATGCAGCGTCTACAGACAGAGAT 
oAV630 ATCTCTGTCTGTAGACGCTGCATCCTGCGATCGGATTATACC 
oAV631 GGTCTCAGGATGTACGGTCTACAGCCGCCGATCGTGTGAAAGTG 
oAV632 CACTTTCACACGATCGGCGGCTGTAGACCGTACATCCTGAGACC 
oAV633 GGATGTACGGTCTACCGATCGAGCTGCTGTGAAAGTGATAGAATG 
oAV634 CATTCTATCACTTTCACAGCAGCTCGATCGGTAGACCGTACATCC 
oAV635 GGGCGCAAGTTTTAGCAGCCGGCGACGGA ACCAACTACTATTTG 
oAV636 CAAATAGTAGTTGGTTCCGTCGCCGGCTGCTAAAACTTGCGCCC 
oAV653 CGGGAGATATTGTTCGAGCTCAAGTTTTAGCATTAGGTGACGG 
oAV654 CCGTCACCTAATGCTAAAACTTGAGCTCGAACAATATCTCCCG 
oAV655 CGGGAGATATTGTTCGAGCTCAAGTTTTATCAGCAGGTGACGG 
oAV656 CCGTCACCTGCTGATAAAACTTGAGCTCGAACAATATCTCCCG 
oAV657 GGTGGATTGATGGCTGCTACAGACTGGCAAATGATGACTAGTCCG 
oAV658 CGGACTAGTCATCATTTGCCAGTCTGTAGCAGCCATCAATCCACC 
oAV659 GGTGGATTGATGTATGCTGCAGACTGGCAAATGATGACTTCACCG 
oAV660 CGGTGAAGTCATCATTTGCCAGTCTGCAGCATACATCAATCCACC 
oAV661 CGCCTGCAGCAAAAGGTTTGGCACATTTGCGCTTTTCTGTAGCGCC 
oAV668 CGCTCTAGAATGCTTCCTGGGACAGAAAAGGGTCGTAAAACCAACAAATATGCTAAT 
oAV669 CGCTGCAGCATTCCTTGCAGTGGTCAAATAGTAGTTGGTTCCGTCACC 
oAV670 CGCTCTAGAATGGACCTTGGGGTCGTGTTCGCCAGAGCTGCTAATGGTGCTGGTGG 
oAV699 CGCCTGCAGC ATTATTAGCATATTTGTTGGTTTTACGACCC 
 
oAV700 CCACTGCAAGGAATGCCGCTGGGGTCGTGTTCGCCCGAGCTGCT 
oAV701 AGCAGCTCGGGCGAACACGACCCCAGCGGCATTCCTTGCAGTGG 
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Table 2-3. Primers used (continued)  
Name Sequence 
oAV702 GGAATGACCTTGCGGTCGTGTTCGCCCGAGCTGCT 
oAV703 AGCAGCTCGGGCGAACACGACCGCAAGGTCATTCC 
oAV704 GGAATGACCTTGGGGCCGCGTTCGCCCGAGCTGCT 
oAV705 AGCAGCTCGGGCGAACGCGGCCCCAAGGTCATTCC 
oAV706 GGTGCCGGCGGATTGGCGTATGCTACAGACTGGC 
oAV707 GCCAGTCTGTAGCATACGCCAATCCGCCGGCACC 
oAV708 GCTACAGACTGGCAAATGGCGACTTCTGCAGTTACAGGCGC 
oAV709 GCGCCTGTAACTGCAGAAGTCGCCATTTGCCAGTCTGTAGC 
oAV710 CCGGTTACAGGCGCTACAGCCAAGGCGGCATGTGCCAAACC 
oAV711 GGTTTGGCACATGCCGCCTTGGCTGTAGCGCCTGTAACCGG 
oAV712 CGCTACAGAAAAGCGCAAATGTGCCGCACCTTTTTAAGGATCC 
oAV713 GGATCCTTAAAAAGGTGCGGCACATTTGCGCTTTTCTGTAGCG 
oAV723 GCGGGATCCTCATTTGTCATCGTCGTCCTTGTAGTCATTATTAGCATATTTGTTGGTTTTACGACCC 
oAV724 GCGGGATCCTCATTTGTCATCGTCGTCCTTGTAGTCATTCCTTGCAGTGGTCAAATAGTAGTTGGTTCCG
TCACC 
oAV725 GCGGGATCCTCATTTGTCATCGTCGTCCTTGTAGTCAAAAGGTTTGGCACATTTGCGCTTTTCTGTAGC 
oAV746 CGCTACAGAAAAGCGCAAATGTGCCGCACCTTTTGCTGCAGG 
oAV747 CCTGCAGCAAAAGGTGCGGCACATTTGCGCTTTTCTGTAGCG 
oAV748 CGC GCTGCAGGT TCTACGTTCATATTCCCTGGTGATAGCTTTCCTGTAG 
oAV751 CCAGAAATAGCTTATCCAGGTAAGCTTGCATGCCCACAGTACGG 
oAV752 CCGTACTGTGGGCATGCAAGCTTACCTGGATAAGCTATTTCTGG 
oAV753 GTAAAAAATATTGCGGTTGCAGTGCTTCCTGGTACCGAAAAGGGT 
oAV754 ACCCTTTTCGGTACCAGGAAGCACTGCAACCGCAATATTTTTTAC 
oAV886 GATCTCTTCAAAAGTGCACCCATTTGCAGGTGCTCC 
oAV887 TCGAGGAGCACCTGCAAATGGGTGCACTTTTGAAGA 
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Figure 2.1 Depiction of the TAP tag cloning. Protein sequence, either full-length or 
truncated, was fused at the C-terminus with the TAP tag in the manner depicted above in 
order to place both sequences in frame. The blue line depicts the nucleotide sequence and 
the resulting amino acid sequence between the TAP tag and the protein of interest is 
depicted on the bottom in red.  
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Cytoplasmic mRNA degradation assay 
   Cytoplasmic mRNA degradation assays were performed essentially as described 
(van Hoof et al., 2000b). Briefly, to test if a protein is involved in the 35’ 
cytoplasmic mRNA degradation pathway, a strain deleted for the particular protein 
was supplemented with a plasmid encoding that same protein or a mutant. The 
strain also had a dcp1-2 temperature-sensitive allele of DCP1. Transformants were 
grown on selective medium at room temperature.  Next, growth assays were 
performed, as described above, at room temperature, 30oC and 37oC. Since the 
dcp1-2 allele is temperature-sensitive, at non-permissive temperature this strain 
does not have a functional 5’3’ decay pathway and can only survive if the 3’5’ 
pathway is functional. The functionality of the 3’5’ would be provided for by the 
plasmid-encoded protein.   
 
Nonstop mRNA degradation assay  
   This assay was completed as described (van Hoof et al., 2002). Briefly, a strain 
with a deletion of one gene on the chromosome, complemented with a mutant allele 
of that gene on a plasmid, was transformed with a vector carrying a mutant his3 
gene which lacks a stop codon, his3-nonstop. After selecting for transformants, 
growth assays were performed as described above, on SC-His medium. Strains that 
are proficient in nonstop mRNA degradation rapidly degrade the his3-nonstop 
mRNA which leads to failure to grow on SC-His medium. Strains that are deficient in 
nonstop mRNA degradation do not recognize the his3-nonstop as aberrant mRNA 
and do not degrade it, which allows for the production of histidine and the strain 
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grows. The positive control used for this assay was a ski7 strain because ski7 
does not have nonstop mRNA decay. 
 
Protein isolation 
  Total protein was isolated form S. cerevisiae using the alkaline lysis method. 
Briefly, cells were grown to OD600 = 0.8 and 4 OD units of cells were removed, 
centrifuged, the supernatant was removed and the cell pellet was suspended in 150 
ml of lysis solution (1.85 M NaOH with 1% -mercaptoethanol) and incubated on ice 
for 10 minutes. 75 ml TCA were added to precipitate the protein and the precipitated 
protein was pelleted using centrifugation. The protein pellet was then washed with 1 
ml  acetone, resuspended in 100 ml of 2x loading buffer and heated at 65oC for 10 
minutes to dissolve. 10 l of sample was used for the Western blotting. 
 
Western blotting 
   Proteins were resolved on 10% SDS-polyacrylamide gel and transferred onto 
nitrocellulose membrane using electrophoresis (Towbin et al., 1979). The 
membrane was blocked in 5% milk in TBST (Tris-Buffered Saline with 1ml/L 
Tween® 20), and then treated with primary antibody for 1 hour, washed three times 
in TBST, treated with secondary antibody HRP conjugated for 1 hour, washed again 
three times in TBST, and the proteins were detected using ECL Plus Western 
Blotting Detection Reagents (GE Healthcare) per manufacturer’s protocol.  
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Co-immunoprecipitation (Co-IPs) 
   Co-IPs were completed as described (Schaeffer et al., 2012). Briefly, cells were 
grown to OD600 0.8, centrifuged, and the cells were collected and washed with 
ddH2O. The cell pellet was resuspended in 200 l of cold IP50 buffer (50 mM TRIS-
HCl pH7.5, 50 mM NaCl, 2 mM MgCl2, 0.1% Triton) + 0.5M EDTA, 1 M -
mercaptoethanol, 0.1 mM PMSF, and 1 “Mini-complete protease inhibitor tablet 
EDTA free”( Roche) per 10 ml  of buffer. The above sample was vortexed with glass 
beads for 7 min at 4oC, centrifuged, the supernatant was collected and total protein 
was quantified in spectrophotometer using Biorad protein assay Dye reagent. 40 mg 
of total protein was used for the Western blotting. 
 
RNA isolation 
   RNA was isolated by the “Hot phenol” method essentially as described (He et al., 
2008). Briefly, cells were grown to OD600=0.6 and collected by centrifugation and 
removal of the supernatant.   500 l of RNA buffer A (0.5 M NaoAc, 0.01M EDTA, 
1% DEPC 1% SDS) was added  to the cell pellet followed by  500l of RNA 
Phenol/BufferA 1:1 ratio, heated to 65oC. The mixture was heated to 65oC for 4 
minutes, centrifuged, upper aqueous layer mixed with 500 l of RNA/BufferA was 
heated to 65oC again for 4 min. and the previous step repeated. Next, the upper 
aqueous layer was mixed with 500l of Buffer A +TE/Chloroform at room 
temperature (Phenol: Chloroform is 1:1 ratio) then centrifuged and upper layer 
precipitated by the addition of 1 ml of 100% cold ethanol and incubating at -80oC for 
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at least one hour. Ethanol was removed and replaced  with 70% ethanol and then 
the 70% ehtanol was replaced with DEPC treated water. RNA pellet was 
resuspended by 5 freeze/thaw cycles and absorbance was measure at 260nm. 
 
RNA gel electrophoresis 
   Polyacrylamide gels (11.25 ml of 40% 19:1 acrylamide:bisacrylamide, 7.5 ml of 
10x TBE, 30 ml of DEPC treated H2O, 34.5g urea, 100l TEMED, 100l 40% APS) 
were run to detect RNA fragments smaller that 500nts  such as 5.8S rRNA. 5’ ETS, 
U4, tRNAs, etc. as indicated in the text. The electrophoresis was run in TBE buffer. 
After resolving the RNA by size, it was transferred onto a nylon membrane using 
electroblotting in 0.5x TBE buffer for a total 180 volt hours and then the membrane 
was subjected to UV crosslinking. 
   1.3% agarose gels (72 ml  ddH2O, 18 ml  formaldehyde, 1.3% agarose, 5L 10 
mg/ml  ethidium bromide 10 ml  10x MOPS buffer,) were run for detection of iron 
response mRNAs FIT3 and TIS11. MOPS buffer is 41.8 g MOPS (3-(N-
morpholino)propanesulfonic acid), 16.6 ml  NaAc, 20 ml  0.5 M EDTA in 1L H2O, pH 
7.0. Agarose gels were run in 1x MOPS buffer and transferred overnight via 
capillary action onto nylon membranes and then the membrane was subjected to 
UV crosslinking. 
 
 
 
 
 
38 
 
Northern blotting 
   The sequences of all oligos used as probes for northern blotting are listed in Table 
2.3. All probes were 32P 5’ -phosphate - labeled. 
   Northern blot analysis was performed as described (Meaux and Van Hoof, 2006). 
Briefly, nylon membranes onto which RNA was transferred, either from 
polyacrylamide or from agarose gels (see above), were washed with prewash buffer 
(0.1x SSC, 0.1% SDS) at 65oC for 1 hr, then prehybridized in prehybridization buffer 
(10x Denhardt’s solution, 6x SSC, 0.1% SDS) at 42oC  for 1 hr and probed 
overnight in the same buffer with added radioactively labeled probe at 42oC. 
Membranes were washed in wash buffer (6xSSC,0.1% SDS) 3 times (for 5 min, 5 
min, and 20 min) and signals were detected by exposing phosphor screens for 
empirically determined amount of time and visualized using a STORM840 
PhosphorImager (Amersham). A probe for the RNA component of the Signal 
Recognition Particle was used as a loading control for both agarose and 
polyacrylamide gels. 
 
-galactosidase assay  
   -galactosidase assays were completed per manufacturer’s instructions 
(Promega). Briefly, cells were grown to OD600=0.6. 50 l of cell culture was mixed 
with 50 l of Beta-Glo reagent (Promega). The mixture was incubated for 30 min.  at 
room temperature in 96-well plates and light output and OD600 were measured using 
Biotech Synergy MX plate reader. Light output was normalized to OD for each well. 
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ROS detection assay 
   ROS detection assays were completed after optimization as suggested by the 
manufacturer (Life technologies). Overnight cultures were diluted to OD600=0.2, then 
after growing for 1.5 hr were either treated with H2O2 (for the cells that were 
oxidatively stressed) or left untreated. After 1hr treatment 1 ml of culture was 
centrifuged and the medium was removed. The cells were washed in phosphate 
buffered saline (PBS), resuspended in 1 ml PBS and 252',7'-
dichlorodihydrofluorescein diacetate (H2DCFDA) was added. Fluorescence was 
detected at 525 nm with excitation at 495 nm and Relative Light Units were 
normalized to OD in each sample and then all samples were normalized to wild-
type. 
 
Glucose utilization assay 
   To measure percentage of glucose in the medium, cells were grown in liquid YPD 
culture as described for 24 hr.  OD600 was measured every two hours and at the 
same time 1 ml of culture was removed and frozen for analysis. Glucose was 
measured using Glucose (HK) Assay Kit (Sigma) used per manufacturer’s 
instructions. 
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Ethanol output assay 
    Ethanol was measured using EnzyChomTM Ethanol Assay Kit (BioAssay 
Systems) per manufacturer’s instructions. 
 
  
 
 
 
41 
 
 
Table 2-4. Oligonucleotides used for Northern blotting 
Name Target Sequence 
oAV224 SRP GTCTAGCCGCGAGGAAGG 
oAV777 5.8S rRNA TTTGCGTGCGTTCTTCATC 
oRP756 U4  
oAV872 TIS11 GGGAGTTTCCTGCACTTGGC 
oAV873 FIT2 CGACGGCTTGAGTGACGGTC 
oAV973 Rnase P GTTCGCCACTAATGACGTCC 
oAV976 precursor to tRNA Arg-
Asp 
AGAAACAAAGCACTCACGAT 
oAV978 tRNA Glu CCGAAGCGGGGAGTCGAACCC 
oAV979 tRNA Asp CCGCGACGGGGAATTGAACCC 
oAV981 CAF20 CGTCGTCTTCGTCTTCACTTTCC 
oAV982 REV1 CTTTCCCACGTTTGGAAGCC 
oAV983 YMR304C-A GCTTTTAGGTAATGCCGC 
oAV1025 ATM1 GCCCGAAGACCCAACTATTGCGG 
oAV1137 CYB2 CGGTAGAACCGTACGCGCGG 
oAV1138 CYT1 GCTGGGGCGTGCAATCCGTG 
oAV1141 RIP1 CCTGTACGTGGATTTGCTAGCCAGC 
oAV1142 COR1 GCCAAAGACCTCTTGAACTGG 
oAV1151 5' ETS CGAACGACAAGCCTACTG 
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Chapter 3: Characterization of Rrp4 and Rrp40 RNA binding proteins of the 
exosome  
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INTRODUCTION 
    Currently, it is unknown how the exosome recognizes substrate RNAs. 
Recognition is likely to occur at the site of RNA entry where the three cap proteins 
of the exosome are located. Because of their location and because each of the cap 
proteins contains a known nucleic acid binding domain, S1, the cap proteins are 
likely candidates to bind RNA and/or exosome cofactors.  Therefore, they may be 
important for providing specificity to the exosome.  
   Mutations in the human ortholog of Rrp40, hRrp40, have been associated with 
various human diseases, suggesting the importance of this particular protein to 
human physiology, particularly in neurological conditions.  For example, mutations 
in hRrp40 V80F and D132A are associated with early onset spasticity, distal 
amyotrophy, and cerebellar atrophy (Zanni et al., 2013). Additionally, mutations 
G31A, A139P, D132A, and W238A have been associated with Pontocerebellar 
hypoplasia type 1 (Biancheri et al., 2013; Rudnik-Schoneborn et al., 2013; 
Schwabova et al., 2013; Wan et al., 2012). Therefore. characterizing the cap 
proteins of the exosome is important for understanding basic cellular RNA 
metabolism, but also may have implications for the improvement of human health.  
   Two of the cap proteins, Rrp4 and Rrp40 share almost identical domain 
organization. Each has an N-terminal RPL27-like domain connected to the middle 
S1 domain by a linking sequence, and a KH (K homology) domain (Figure 3-1).  
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   The N-terminal domains of Rrp4 and Rrp40 are similar to a domain found in 
ribosomal protein Rpl27, which is involved in protein-protein interactions, thus they 
are referred to from now on as RPL27-like domains. Other than this similarity, 
nothing much is known about these domains. With regards to their interactions with 
the PH ring of the exosome, the RPL27-like domain of Rrp4 interacts with Rrp41, 
while the RPL27-like domain of Rrp40 interacts with Rrp46 (Liu et al., 2006). 
   The S1 domains are well known RNA binding domains, first identified in the 
ribosomal protein S1 (Subramanian et al., 1981). These domains are found in many 
RNA binding proteins and are highly conserved from prokaryotes to eukaryotes. All 
three major exoribonucleases of E. coli,  RNase II, RNase R, and PNPase, contain 
S1 domains. In eukaryotes, in addition to all three cap proteins of the exosome, S1 
domains are found in the initiation factor 2 (eIF2) and in proteins important for 
releasing mRNAs from the spliceosome such as Prp22 and dead box protein 8. It  
has been shown that S1 domains have specific target sequences along the RNA 
(Boni et al., 1991). However, there does not seem to be any major difference from 
one S1 domain to another with respect to binding of particular RNAs. The  S1 
domain of RNase II was successfully swapped with the S1 domains of either RNase 
R or PNPase, even though there was some loss of activity (Amblar et al., 2007). 
Thus it seems that the S1 domains were functioning best when in the context of the 
protein with which they evolved. Further, the same study showed that neither the 
degradation properties, nor the ability to deal with secondary structures were related 
to the S1 domains, but the S1 domains were capable of inducing multimerization.  
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B 
  
Figure 3-1 Domain organization of Rrp4 and Rrp40. A. Depiction of domain organization 
of  the Rrp4 and Rrp40 protein sequences. The numbers indicate residue number. Arrows 
above Rrp40 point to residues corresponding to disease-causing mutations in human Rrp40 
(hRrp40). G8=hRrp40 G31, P36=hRrp40 V80, S87=D132, V95=hRrp40 A139, 
W195=hRrp40 W238.  B. A view of the exosome from the cap protein side. Shown is the 
location of the cap proteins in relation to the PH ring proteins.  
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   Finally, both proteins have a KH domain at their C-terminal end. KH domains are 
nucleic acid binding domains, fist identified in the human heterogeneous nuclear 
ribonucleoprotein (hnRNP) K (Baber et al., 1999; Siomi et al., 1993). KH domains 
are often found in repeats and can function either independently or cooperatively 
with the other KH domains (Garcia-Mayoral et al., 2007). Like the S1 domains, they 
are also conserved though evolution and are found in bacterial proteins, such as 
PNPase of E. coli and also in numerous eukaryotic proteins. The best known 
example is Fragile mental retardation 1(FMR1) a mutation in which causes fragile X 
syndrome (Gibson et al., 1993). The KH domains are a rare case in which there are 
two folds, type I and type II, that  result from the highly similar sequences of the KH 
motifs (Grishin, 2001). Interestingly, while Rrp4 and Rrp40 share similar structure 
along their other domains, there are significant differences in their KH domain 
topologies (Liu et al., 2006). The effect of these differences is not known. 
   Both Rrp4 and Rrp40 are essential proteins. However, given their high sequence 
homology, it would be unusual that the domains are needed for the essential 
function of the exosome versus having redundant roles. There are three possible 
functions of Rrp4 and Rrp40. First, they may play a structural role in the assembly 
of the exosome complex. When the human exosome structure was solved the 
authors were unable to assemble the PH ring without including the three cap 
proteins which strongly suggested that at least one of the cap proteins was needed 
for the exosome to assemble (Liu et al., 2006). Second, they may bind substrate 
RNA destined for degradation or processing by the exosome. This is based on the 
fact that each of these proteins contains two RNA binding domains. Third, Rrp4 and 
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Rrp40 may provide a platform for binding other protein cofactors of the exosome. 
And finally, these three possible functions of the cap proteins are not mutually 
exclusive. Therefore the purpose of this study is to determine the role of Rrp4 and 
Rrp40 in the exosome.  
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RESULTS 
 
All of the domains of Rrp4 are essential 
   Even though both Rrp4 and Rrp40 are essential, it is not know which of their 
domains are responsible for their essential role. To determine which domain of Rrp4 
is responsible for the essential function, several truncations of Rrp4 were 
constructed: rrp4RPL27-like, rrp4RPL27-like +S1, rrp4S1+KH, and rrp4KH which 
had the RPL27-like domain, the RPL27-like + S1 domain, the S1+KH domain, and 
only the KH domain respectively. Each of the truncations was inserted into a vector 
with the LEU2 marker and the truncations were between the native 5’ and 3’ UTRs 
of Rrp4. Two different methods were chosen to test the ability of these constructs to 
substitute for the essential function of Rrp4: introducing the constructs in strains in 
which Rrp4 was deleted and introducing them into a strain in which Rrp4 could be 
shut-off via a galactose-regulated promoter. 
   First, a strain with rrp4 on the chromosome, complemented by a vector with wild-
type RRP4 and an URA3 marker, was transformed with the LEU2 plasmids with the 
truncations and transformants were selected on SC-Leu-Ura. Next, a plasmid 
shuffle assay was carried out by growing the transformants on 5FOA to select for 
strains that have lost the URA3 plasmids (for more details on the plasmid shuffle 
assay refer to Chapter 2 Materials and Methods). If any truncation was able to 
substitute for the essential function of Rrp4 then the strain in which it is transformed 
would be able to grow on 5FOA. None of the constructs grew on 5FOA indicating 
that they were unable to substitute for the essential role of Rrp4 (Figure 3-2 A).  
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   To confirm these results in an independent way, the same constructs were used 
to transform a strain in which Rrp4 is under the control of the GAL promoter 
(GAL_RRP4) allowing for shutting off the expression when glucose is added to the 
medium. Transformants with truncations that were grown on medium with glucose 
had a growth rate similar to the negative control (an empty vector), indicating that 
they could not substitute for the essential role of Rrp4 (Figure 3-2 B). The little 
growth seen for these constructs as well as for the negative control is probably due 
to minimal expression from the GAL promoter allowing for low level of Rrp4. The 
only construct that was able to complement the Rrp4 shut-off was the full-length 
Rrp4, indicating that the truncations were not able to substitute for the essential role 
of Rrp4. 
   To confirm that the truncated proteins were expressed, the truncations were 
tagged with a TAP tag (Rigaut et al., 1999) at their C-terminal end. The TAP tag has 
a Protein A moiety as a part of it, therefore expression was confirmed by a Western 
blot probed with anti-Protein A antibody (Figure 3-2 C). Each truncation was 
expressed to a level comparable to wild-type Rrp4 indicating that the truncations 
were not viable for reasons other than lack of protein expression. A growth assay 
with these TAP-tagged truncations was also conducted in rrp4 strain to verify that 
the TAP tag did not alter the phenotype (Figure 3-2D). The full length TAP-tagged 
Rrp4 grew as well as the untagged Rrp4 indicating that the TAP tag did not cause 
alteration in the growth phenotype. Therefore the truncation and TAP tag addition 
did not affect the expression and the essential role of Rrp4.  
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   Given all of the above data, it was concluded that all of the domains of Rrp4 are 
essential for life, as none of the truncations could substitute for the essential role of 
the full-length Rrp4. 
 
All of the domains of Rrp40 are essential 
   To determine the essential domains of Rrp40, similar sets of experiments as for 
Rrp4 were carried out. Truncations of Rrp40 were created- Rrp40RPL27-like, 
Rrp40RPL27-like +S1, Rrp40S1+KH, and Rrp40KH. In the case of Rrp40, in 
addition to the knock-out, and GAL-regulated Rrp40, a temperature sensitive allele 
of Rrp40 was also used. 
   First, a plasmid shuffle assay with the Rrp40 truncations introduced into an rrp40 
strain was conducted in the same way as for the rrp4strain. None of the 
constructs grew on 5FOA indicating that they were unable to substitute for the 
essential role of Rrp40 (Figure 3-3 A).  
   Second, a strain with GAL promoter regulated Rrp40 was transformed with 
vectors bearing each of the truncations and was grown on medium supplemented 
either with glucose or galactose. Figure 3-3B shows that only the full length Rrp40 
was able to substitute for the lack of Rrp40.  
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Figure 3-2. All of the domains of Rrp4 are essential. A. Plasmid shuffle assay of the 
depicted truncations of Rrp4 in an rrp4 strain (Schaeffer et al., 2009). B. The depicted 
truncations were transformed into a strain in which Rrpp4 is under the control of the GAL 
promoter (GAL_Rrp4) and grown either without galactose (SC-Leu) or with galactose and 
sucrose (SC-Leu+Gal+Suc). C. Western blot analysis of the depicted truncations of Rrp4.  
D. Plasmid shuffle assay of the depicted truncations of Rrp4, TAP-tagged, in an rrp4 
strain. 
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Third, a strain bearing a temperature sensitive allele of Rrp40, mtr14-1, (Smith et 
al., 2011) was transformed with each of the vectors encoding the Rrp40 truncations. 
After selecting for transformants at room temperature, they were transferred to 
either non-permissive temperature at 36oC or grown at the permissive temperature 
of 23oC. As with the previous two assays, only full length Rrp40 was able to 
substitute for the essential role of Rrp40 ( Figure 3-3D).  
   To determine if each truncation was expressed, the truncations were tagged with 
a TAP tag at their C-terminus. A Western blot was conducted (Figure 3-3C) and 
confirmed the expression of only the full-length Rrp40 and the truncation with only 
KH domain. There was also a very low level expression of the Rrp40RPL27-like 
+S1 truncation, but no visible bands for Rrp40RPL27-like or Rrp40S1+KH. The 
reason why some of the Rrp40 truncations were not expressed is not known, but is 
possible that factors related to proper protein folding may play a role. These data 
suggest that all of the domains of Rrp44 are needed for exosome function, but in 
the case of the non-expressed truncation a stability issue due to improper folding 
cannot be ruled out.  
 
The cap proteins have unique essential roles. 
   Because Rrp4 and Rrp40 are so similar in their domain organization, it is possible 
that one of them can substitute for another. To test if each of them has a unique 
role, each was overexpressed into a deletion strain of the other. Because the  
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Figure 3-3.  All of the domains of Rrp40 are essential. A. Plasmid shuffle assay of the 
depicted truncations of Rrp40 in an rrp4 strain (Schaeffer et al., 2009). B. The depicted 
truncations were transformed into a strain in which Rrp40 is under the control of the GAL 
promoter (Gal_Rrp4) and grown without galactose (SC-Leu) and with galactose and 
sucrose (SC-Leu+Gal+Suc). C. Western blot analysis of the depicted truncations of Rrp40 
D. The depicted truncations were transformed into a strain with temperature sensitive 
Rrp40 (Rrp40 ts) and grown at permissive (23oC) and non-permissive (36oC) temperature. 
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deletions strains already have the rest of the exosome genes on their 
chromosomes, the additional genes were introduced behind the strong and 
inducible GAL promoter and in a 2 vector, in order to overexpress the protein. 2 
vectors are high copy vectors used for high expression (Futcher and Cox, 1984). 
There are two reasons for designing the assay this way. First, it is possible that 
deletion of one protein, either Rrp4 or Rrp40, is stoichiometrically unfavorable and 
even if the other protein can substitute for the essential function, there isn’t enough 
of it available. Such situation would lower the total number of exosome complexes 
in the cell to a minimum of half of the original. If however, the other protein is 
overexpressed, it may be able to substitute for the essential function of the other. 
Second, increasing concentration of proteins by overexpression increases their 
chance of interacting with lower affinities. Therefore, even if Rrp40 has weaker 
interaction with the exosome at the place of Rrp4 (and vice versa), overexpressing it 
will increase the chance for interaction. Additionally, since the third cap protein Csl4, 
also has a similar domain, it was also included in the assay. The transformants 
were grown on 5FOA + galactose. 5FOA was used to select for transformants that 
have lost the plasmid with the URA3 marker (wild-type gene) and galactose was 
used to induce expression from the vector. None of the proteins were able to 
substitute for any of the other two cap proteins (Figure 3-4).  In each strain, the only 
transformants that grew were the ones transformed with the corresponding protein 
for positive control.   
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Figure 3-4. Overexpression of each cap protein in a deletion strain of the other cap 
proteins A plasmid shuffle assay of A. rrp4 B. rrp40 and C. csl4 strain transformed with 
the indicated vectors in which each of the cap proteins was under the control of the GAL 
promoter. 
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The above data indicate that Rrp4, Rrp40, and also Csl4, have unique roles that 
cannot be substituted by overexpressing another one of the cap proteins. 
 
The homologous domains of Rrp4 and Rrp40 are not interchangeable 
   As mentioned earlier, there is a possibility that the essential role of Rrp4 and 
Rrp40 is structural, functional, or both. Since the data so far indicated that each of 
the domains of Rrp4 and Rrp40 is needed for exosome function, either one of these 
possibilities could not be ruled out. The structural role for either Rrp4 or Rrp40 
would be to bridge two dimers of the exosome PH-ring subunits. One way to check 
for a structural role is to express the proteins as separate domains, in trans. 
However, not all truncations of Rrp40 were stable, therefore it is impossible to 
express Rrp40 in trans. Conversely, all truncations of Rrp4 were expressed at levels 
comparable to wild type.   
   To verify that at least one of the roles for Rrp4 is structural, an in trans expression 
assay was conducted. Briefly, rrp4 strain with a wild type Rrp4 on an URA3 vector 
was transformed with the following truncations: one clone was transformed with 
rrp4RPL27-like on LEU2 vector and rrp4S1+KH on HIS3 vector; another clone was 
transformed with rrp4RPL27-like +S1 on a LEU2 vector + rrp4KH on a HIS3 vector. 
The transformants were then transferred to 5FOA plates to select for los of the 
URA3 (with wild-type Rrp4) vector. Neither of the two combinations of Rrp4 
domains expressed in trans was able to complement an rrp4, only the full length 
Rrp4 was able to complement it (Figure 3-5 A) suggesting that Rrp4 may play a 
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structural role in the exosome. This is consistent with the idea that Rrp4 is important 
for the exosome structure by bridging two dimers of the exosome PH-ring. 
   Since some of the truncations of Rrp40 were not stable on their own, we decided 
to make various chimeras of Rrp4 and Rrp40. The purpose of this experiment was 
to test whether the particular location of the domains was important for growth. Six 
chimeric proteins were made in which various domains were combined (for 
depiction see figure:3-5 B and C) rrp4 RPL27-like _rrp40S1+KH, rrp4 RPL27-like 
+S1_rrp40KH, rrp40RPL27-like _rrp4S1+KH, rrp40RPL27-like +S1_rrp4KH, 
rrp4RPL27-like _rrp40S1_rrp4KH, and rrp40RPL27-like _rrp4S1_Rrp40KH. Each of 
these chimeras was introduced into strains with a deletion of either RRP4 (rrp4) or 
RRP40 (rrp40). In rrp4, only the positive control, a plasmid bearing a full length 
Rrp4, was able to complement a deletion (Figure 3-5 B) and in rrp40 only the 
positive control, a full length Rp40, was able to complement a deletion (Figure 3-5 
C).  
   Transforming chimeras in single deletion strains of either rrp4 or rrp40 has the 
possibility of changing the stoichiometry of the possible exosome complex because 
the resulting strain never has one of each domains. For example an rrp4 strain 
transformed with a chimera rrp4 RPL27-like +S1_rrp40KH will have two KH 
domains from Rrp40 and no KH domain from Rrp4.  To correct for that a domain 
switch experiment was also conducted in double deletion rrp4rrp40 mutants. 
Neither the RPL27-like, nor the S1, nor the KH domain switch was able to  
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Figure 3-5 Rrp4 and Rrp40 have a structural role in the exosome A. Plasmid shuffle 
assay of the expression of Rrp4 in trans(Schaeffer et al., 2009). One of the truncations is on 
a plasmid bearing a LEU2 marker, and the other on a plasmid bearing a HIS3 marker. B. 
Plasmid shuffle assay of the expression of a truncation Rrp4/40 protein in an rrp4 strain. 
The numbers on the pictures indicate from which proteins (4=Rrp4, 40=Rrp40) does the 
indicated domain come (Schaeffer et al., 2009). C. Plasmid shuffle assay of the expression 
of a truncation Rrp4/40 protein in an rrp40 strain (Schaeffer et al., 2009). D Plasmid 
shuffle assay of the expression of Rrp4 and Rrp40 in which a domain has been switched. 
Indicated domains are noted on the left (NT=N terminal domain, S1 domain, or KH domain) 
in a double deletion strain rrp4rrp40 
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complement the double deletion of Rp4 and Rrp40. The inability to switch domains 
also suggests that there is a structural role for Rrp4 and Rrp40. 
 
A conserved phosphorylation is not important for the essential role of Rrp4 or 
for the nonstop mRNA surveilance by the exosome.  
   A conclusion that Rrp4 and Rrp40 have structural roles, does not rule out the 
possibility that they also have functional roles. Both proteins have RNA binding 
domains suggesting that they bind RNA that is to be degraded by the exosome. To 
further look into a possible functional role, a search of two phosphorylation 
databases (PhospoPep and PhosphoGRID) was performed for possible 
posttranslational modifications. There was no evidence that Rrp40 was 
posttranslationally modified, however Rrp4 did have several predicted 
phosphorylation sites, specifically S28, S46, S152, S256, and S268. Only one of 
these phosphorylation sites, S152, was also found to be conserved in human and 
murine Rrp4 homologues and is located in the S1 domain close to where RNA 
enters the central channel of the exosome (Synowsky et al., 2006). This suggested 
that this particular modification was important for function. In order to test if this 
modification was important for viability residue 152 was mutated to alanine to mimic 
the phosphor-free state and to glutamic acid to mimic the phosphorylated state. 
Both mutants grew at wild-type level indicating that neither mutation affected the 
essential role of Rrp4 (Figure 3-6 A). These mutations were also tested by a 
nonstop assay to determine if they affected the cytoplasmic surveillance role of the 
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exosome. Briefly, an rrp4 strain yAV1104 with the Rrp4 phosphorylation mutants 
on a plasmid was transformed with a plasmid with a HIS3 gene in which the stop 
codon is mutated (his3-nonstop) pAV188. The transformants were then grown with 
and without supplemented histidine in the medium. If the his3-nonstop mRNA is 
recognized as aberrant by the exosome, then it is quickly degraded. Thus, that 
strain will not grow on medium lacking histidine. If, however, there is a  problem with 
cytoplasmic nonstop mRNA degradation, then the his3-nonstop mRNA will not be 
degraded, and a protein will be translated which will then allow for growth on 
medium lacking histidine. Figure 3-6 B shows that there is no growth of either point 
mutant indicating that there is no effect on the cytoplasmic mRNA degradation of 
nonstop mRNA by the exosome. Taken together, these data indicate that this 
conserved site of Rrp4 is not important for the essential role of Rrp4 or for the 
nonstop mRNA surveilance of the exosome. 
 
Excess Rrp4 is stable  
   Some studies have suggested that exosome subunits localize to different sites in 
the cell. Specifically, by using indirect immunofluorescence with antibodies to 
endogenous exosome subunits, it was found that in Drosophila melanogaster S2 
cells, various exosome components localize differently (Graham et al., 2006). The 
authors concluded that there may be differently assembled exosome complexes. 
However, a careful analysis of their data shows that Rrp4 was enriched in foci that 
were markedly different from the foci seen for Rrp40 and Rrp42 (a PH ring subunit   
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Figure 3-6. The posttranslational phosphorylation of Rrp4 is not important for 
viability or nonstop mRNA degradation. A. Plasmid shuffle assay of point mutants of 
Rrp4 S152E and S152A. Two independently derived clones of each mutant were plated. 
The location of S152 along the Rrp4 protein sequence is indicated with an asterisk on the 
picture below. B. Non-stop assay (see material and methods) of the same mutants in an 
rrp4 strain.   
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of the exosome) suggesting that Rrp4 may have a role outside of the exosome, 
since it does not localize with a PH ring subunit. Presumably, if such a role exists, 
Rrp4 would be stable on its own, not as a part of the exosome complex. 
   To test if Rrp4 is stable when not associated with the exosome, several 
experiments were completed. First, a wild-type strain was transformed with a 
plasmid encoding full-length, TAP- tagged Rrp4 with a URA3 marker 
(Rrp4_TAP,URA) and a high copy plasmid with GAL regulated full-length Rrp4-
ProteinA with an LEU2 marker( GAL_Rrp4-PtnA, LEU2). The purpose of the 
experiment was to overexpress Rrp4 via the plasmid with the GAL promoter, and to 
verify the level of the total Rrp4 by a Western blot with an anti-Protein A antibody 
that detects the Protein A in the high copy vector and the TAP tag. If Rrp4 is not 
stable when not associated with exosome, it would be expected that the levels of 
the antibody detectable (i.e. TAP-tagged + Protein A tagged) Rrp4 would be the 
same compared to a strain in which there is no GAL_Rrp4-PtnA. However, the 
levels of Rrp4 increased (Figure 3-7 A). The increase seen in the Western blot is 
due to a Protein A moiety that is cloned in frame with the Gal_RRP4 gene, resulting 
in the expression of a Protein A-tagged Rrp4. These data suggest that Rrp4 is 
stable out of the exosome. 
   A second experiment to address the stability of Rrp4 when not in the exosome 
complex was completed. A vector with a Tap-tagged Rrp4 with a LEU2 marker 
(Rrp4_TAP, LEU2), was introduced either in wild-type S. cerevisiae strain or in an 
rrp4 strain, complemented with a wild-type RRP4 allele on a vector with a URA3 
marker (Rrp4, URA3). The strains were then grown on 5FOA to select for the loss of 
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the URA3 vector in the rrp4 strain. Therefore after plasmid shuffle both strains 
have the Rrp4_TAP vector, but the wild-type strain has a chromosomally originating 
wild-type Rrp4 while the rrp4 strain doesn’t. As seen in Figure 3-7 B, both strains 
have the same amount of Rrp4_TAP even though the wild-type strain has the wild-
type Rrp4 on the chromosome. These data also suggest that Rrp4 is stable out of 
the exosome complex.  
   A third experiment was completed for an additional confirmation of the stability of 
Rrp4 out of the exosome complex. This experiment utilizes temperature sensitive 
mutants of components of the cap, the PH ring, and the catalytic subunit.  The 
mutants were a temperature-sensitive mutant of Mtr3, mtr3-1, a temperature-
sensitive mutant of Rrp40, mtr14-1, and a temperature sensitive mutant of Rrp44, 
mtr17-1. These mutations were discovered as a part of a screen for mutants 
defective in nuclear mRNA export (Kadowaki et al., 1994). Each one of these 
strains and a wild-type strain were transformed with a vector with Rrp4_TAP and 
incubated at permissive (23oC) and non-permissive (37oC) temperature and then 
the amount of Rrp4_TAP was determined and compared. As seen from the results 
in Figure 3-7 C, there was no change in the amount of Rrp4_TAP in any of the 
strains at both temperatures. The results of this assay taken together with the first 
two experiments suggest that when Rrp4 is in excess, it is stable.  
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Figure 3-7 Rrp4 is stable out of the exosome complex. Western blots probed with either 
anti-ProteinA antibody (PtnA) or anti-Pgk1 for loading control. A. Wild-type S. cerevisiae 
strain, transformed with a plasmid with Rrp4_TAP and either GAL_Rrp4-PtnA or empty 
vector. B. Rrp4_TAP was introduced to either WT (ln1) or rrp (ln2) strain. Ln3 is a 
negative control WT+ vector. C. Temperature sensitive strains (listed below the Western 
blots) were transformed with an Rrp4_TAP and grown at the indicated temperatures. – 
(very right lane) is WT strain transformed with an empty vector control, grown at 23oC. 
  
 
 
 
65 
 
DISCUSSION 
   The data presented in this chapter begin to uncover the possible roles of the two 
RNA binding proteins Rrp4 and Rrp40. I have determined that the essential function 
of Rrp4 and Rrp40 does not lie only in one domain, but rather expression of the 
entire proteins is necessary for life. Additionally, Rrp4 and Rrp40 have unique roles 
that cannot be substituted by the other one, despite having such a similar domain 
organization. However, the data about the unique domain roles may not be valid 
because after this study was concluded, a new crystal structure of the exosome was 
published where the domain organization of Rrp4 and Rrp40 was changed (Makino 
et al., 2013). In particular there is a large difference of the boundaries of the S1 
domain of Rrp40 which may have affected the results of the S1 domain switch 
(Figure 3-8).  
   One line of evidence presented here points to a structural role for both Rrp4 and 
Rrp40. First, both the RPL27-like and the KH domains of Rrp4 and Rrp40 are 
essential. Second, the RPL27-like domain of Rrp4, which interacts with Rrp41, and 
the RPL27-like domain of Rrp40, which interacts with Rrp46 are not 
interchangeable. The KH domains of both proteins are also not interchangeable. 
The KH domain of Rrp4 interacts with Rrp42, and the KH domain of Rrp40 interacts 
with Rrp43. Third, at least for Rrp4 I have established that the RPL27-like and the 
KH domains need to be in the same polypeptide. These data, taken together with 
data from other studies, specifically that the cap proteins were needed for the 
assembly of the exosome complex (Liu et al., 2006), indicate that Rrp4 and Rrp40 
are needed to provide bridging contacts for the underlying PH ring proteins. After  
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Figure 3-8. Revised domain organization of Rrp4 and Rrp40. A. Domain organization of 
Rrp4 and Rrp40 according to the crystal structure published by (Makino et al., 2013).         
B. Domain organization of Rrp4 and Rrp40 used to create the truncations used in this 
study. 
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this study was concluded, a study was published of  reconstitution of the exosome, 
where the authors show that in vitro only Rrp40 was needed for the assembly of the 
PH ring of the exosome (Malet et al., 2010). While these data support my 
conclusion about the structural role of Rrp40, it does not support a model for a 
structural role for Rrp4. However, since this study was carried out in vitro, it is still 
possible that Rrp4 has a structural role, but that the exosome exists in vivo in two or 
more conformations. Another possible explanation is that Rrp4 may be added late 
during exosome assembly or it may be transiently associated with the exosome. 
Such unstable association may also explain the stability of Rrp4 out of the exosome 
complex, which is discussed below.  
   The presence of multiple RNA binding domains at the site of RNA entry into the 
exosome, points to a functional role for Rrp4 and Rrp40, specifically, binding of 
exosome’s substrates. Point mutations of three basic residues in a loop in the S1 
domain of Rrp4  were lethal suggesting that the essential role of Rrp4 is as a part of 
the exosome because the S1 domain binds RNA destined for degradation (Malet et 
al., 2010). 
   Additionally, Rrp4 seems also to have a functional role outside of the exosome 
complex. This conclusion is based on two separate pieces of data. First, Rrp4 has 
been shown to localize to distinct foci in D. melanogaster (Graham et al., 2006). 
Second, my data show that Rrp4 it not degraded when in excess. What this 
functional role is, is currently unknown. However, other exosome components have 
also been found to have a role outside of the complex. For example, Rrp46 was 
found to assemble in dimers, in addition to its assembly in the exosome (Yang et 
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al., 2010). Therefore it is possible that Rrp4 also has exosome independent roles. 
Future studies may address this possibility. The phosphorylation of Rrp4 suggest 
that there may be an additional regulation needed, for some other role of Rrp4, but 
that this possible role is non-essential given the fact that the phosphorylation itself 
was not essential. The phosphorylation site however was next to the essential basic 
residues that were found to be essential. It would be interesting to determine what if 
any regulation the phosphorylation of Rrp4 exerts on the proteins and what is the 
role of Rrp4 outside of the exosome.   
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Chapter 4. Characterization of the exosome cap protein Csl4  
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INTRODUCTION 
   Csl4 is one of the cap proteins of the exosome, together with Rrp4 and Rrp40. 
Csl4 was first identified in a screen for Cep1 synthetic lethality (Baker et al., 1998). 
Prior to that, a separate screen for viral super killer mutants identified eight so-
called Ski proteins (Toh et al., 1978). It was later discovered that Csl4 is 
homologous to one of the genes identified in the superkiller screen, Ski4, and that it 
is a component of the exosome (Allmang et al., 1999b; van Hoof et al., 2000b). 
   The exosome associates with different proteins in the nucleus and in the 
cytoplasm and it is believed that these associations determine the specificity of 
substrate degradation or processing. However, the mechanism of these cofactor 
associations remains unknown. Csl4 is the only protein of the exosome complex 
which is currently known to have a mutation specifically disturbing cytoplasmic 
mRNA degradation, both for normal and nonstop transcripts. Therefore, Csl4 is a 
likely candidate to mediate the different roles of the exosome in the nucleus and in 
the cytoplasm. 
   Csl4 consists of three domains. The N-terminal domain is structurally related to 
ribosomal protein L27. In the middle of the protein there is an S1 domain which is 
an RNA-binding domain. The C-terminal domain is a Zn ribbon-like domain, which is 
structurally similar to Zn ribbons, but it lacks the cysteine residues characteristic of 
Zn ribbons. Therefore it does not bind Zn (Figure 4-1). For more detailed 
information on the RPL27-like and S1 domains in general, please refer to Chapter 
3. In the Zn-ribbon domain of the archaeal homolog of Csl4 the cysteine residues 
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are present and thus archaeal Csl4 is likely to bind a Zn atom (Buttner et al., 2005). 
In S. cerevisiae Cslp4 also has a linker region between the RPL27-like domain and 
the S1 domain, which is absent from its human homolog. A point mutant csl4-1, in 
the  promoter of Csl4, reduces expression of Csl4 and has been found to be 
defective in rRNA processing while the cytoplasmic mRNA degradation function of 
the exosome was not affected (van Hoof et al., 2000b).  Another mutant, ski4-1, has 
a point mutation G253E located in the Zn ribbon-like domain and is defective in 
mRNA degradation but has normal rRNA processing phenotype (van Hoof et al., 
2000b). These two mutants in effect separate the role of the exosome in the 
nucleus from its role in the cytoplasm.  
   Two general possibilities were considered when aiming to identify what was the 
essential role of Csl4. First, Csl4 could have a structural role in stabilizing the 
exosome complex. When the crystal structure of the human exosome complex was 
solved, the authors reported unsuccessfully trying to assemble just the PH ring 
without the cap proteins Csl4, Rrp4, and Rrp40. They were only able to assemble 
the entire complex once the cap proteins were added (Liu et al., 2006). This 
suggested that the cap proteins, one of which is Csl4, could play a structural role in 
the assembly of the complex. It was not further investigated whether all of them or 
only particular ones were needed for the exosome assembly. A second possible 
role for Csl4 is that it could have a functional role on the exosome complex. No 
enzymatic activity has been identified for Csl4, however it contains potential nucleic 
acid binding domains (S1 and Zn-like) and a possible protein-binding domain 
(RPL27-like), and it is located at the site of the proposed entry of substrate into the 
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exosome (Wang et al., 2007). It is known that the exosome functions with various 
protein cofactors but the locations of interactions between these cofactors and the 
exosome are unknown.  Therefore is it possible that Csl4, being located at the 
proposed entry site of the substrate, mediates entry of the substrate into the 
exosome central channel by interacting with other protein factors, binding 
substrates, or both. This chapter outlines the experiments that were carried out in 
order to identify and distinguish these possible role of Csl4. 
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Figure 4-1 Domain organization of Csl4. Csl4 has three domains; the RPL27-like domain 
is the N-terminal domain, followed by a linker region which is not present in human 
homologues, an S1 domain and the a Zn ribbon-like domain. Numbers indicate residues. 
Point mutants csl4-1 is located in the promoter as depicted, and ski4-1 is located in the Zn 
ribbon-like domain.  
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RESULTS 
Csl4 does not stabilize the exosome by bridging contacts 
   To determine which domain of Csl4 is essential, C-terminal truncations of Csl4 
were created and used in a plasmid-shuffle assay (for details of the assay see 
materials and methods). Briefly, a csl4 strain was transformed with plasmids with 
either wild-type Csl4 or truncated Csl4. The truncations used were Csl4 1-120 
(RPL27-like+linker), Csl4 1-250(RPL27-like +linker+ S1 domains), Csl4 65-
292(linker + S1+Zn ribbon-like domains), and 120-292(S1 + Zn ribbon-like 
domains). Transformants were selected on SC-Leu-Ura. Next, a plasmid shuffle 
assay was performed on 5FOA to determine if any of the truncations could 
substitute for the essential role of Csl4.  It was found that the RPL27-like+linker 
domain was sufficient for viability even after removing the Zn ribbon-like domain and 
the S1+ the Zn ribbon-like domains (Figure 4-2A).  However, based on Csl4’s 
buried surface from the crystal structure of the human exosome, the RPL27-like 
domain should only interact with one of the PH ring subunits, Mtr3 (Liu et al., 2006). 
Therefore a truncation that only interacts with one subunit cannot bridge the 
underlying proteins. These data suggested that the essential role of Csl4 was not in 
stabilizing the exosome by bridging contacts between the PH subunits. In 
confirmation of these results, a paper published in 2007 also indicated that the 
yeast exosome can be assembled without Csl4 in vitro (Wang et al., 2007).  
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The RPL27-like domain and the S1+ Zn ribbon-like domains are redundant for 
the essential function of Csl4 
   To further confirm which domains were essential for the role of Csl4, N-terminal 
truncations of Csl4 were also created and used in a plasmid shuffle assay. 
Surprisingly, the RPL27-like domain was not essential and viability was conferred 
as long as the S1+ Zn ribbon-like domains were expressed in cis (Figure 4-2 A). 
The Zn ribbon-like truncation did not grow (not shown). To clarify whether the S1 or 
the Zn ribbon -like domain contributed to the essential role in the Csl4-S1+Zn-
ribbon-like truncation, the S1 domain was expressed by itself and was found not to 
be sufficient for life (Figure 4-2 B ). Therefore, the S1+Zn ribbon-like domains were 
also sufficient for viability. 
   Expression of the truncations was checked by Western blot using TAP-tagged 
truncations and all but the Zn ribbon-like domains were found to be expressed 
(Figure 4-2 C). Because the Western blot was done using TAP-tagged truncations 
of Csl4, but the initial growth assay was done using untagged truncations, it was 
also verified by a growth assay that the addition of the TAP tag did not alter the 
phenotype of the viable mutants (Figure 4-2 D). The above data indicate that the 
RPL27-like domain and the S1+ Zn ribbon-like domains are redundant for the 
essential function of Csl4. This is consistent with a view that if an exosome- 
interacting domain of Csl4 is expressed the essential function of Csl4 can be carried 
out.  
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Figure 4-2.  The RPL27-like domain and the S1+ Zn ribbon-like domains are 
redundant for the essential function of Csl4. A and B Plasmid shuffle assay. csl4 strain 
was transformed with plasmids with the indicated truncations and LEU2 markers. C. A 
Western blot of the depicted TAP-tagged truncations of Csl4. PGK1- loading control. D. 
Plasmid shuffle assay. csl4 strain was transformed with plasmids with the indicated 
truncations with a C-terminal TAP tag and LEU2 markers. 
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Because it was determined that Csl4 does not stabilize the exosome by bridging 
interactions, to further characterize its role (both essential and non-essential), 
several possibilities were addressed using the viable truncations of Csl4. First, the 
nuclear function of the exosome was tested; second, the cytoplasmic function of the 
exosome was tested; third, posttranslational modifications were tested; fourth, 
conserved surface residues were mutated. 
 
   The ZN ribbon-like domain is required for the known functions of the 
cytoplasmic exosome. 
   To correlate the growth data with known biological roles of the exosome, the 
domains of Csl4 that were found to sustain viability, were tested for the known 
nuclear roles of the exosome. Specifically, I tested the 7S pre-rRNA processing and 
5’ ETS degradation, which are known to be affected in exosome depletions 
(Allmang et al., 1999a). The processing of the 7S pre-rRNA was slightly affected in 
the truncation bearing only the RPL27-like domain, but unaffected in other viable 
truncations. There was no effect on the final 5.8S rRNA processing and on the 
degradation of the 5’ ETS (Figure 4-3). This indicated that viable Csl4 truncations 
behaved almost as wild type in rRNA degradation and processing.  
   The same domains were also tested for known cytoplasmic exosome roles, 
specifically cytoplasmic mRNA degradation and nonstop mRNA degradation.  
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Figure 4-3 Viable truncation of Csl4 behave as wild type for rRNA processing and 
degradation.  Northern blot analysis of csl4 strain transformed with the indicated 
truncations. The RNA for which it was probed are listed on the left of the pictures. SRP (the 
RNA moiety of the signal recognition particle) is used as a loading control.
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Figure 4-4 Cytoplasmic mRNA degradation and nonstop mRNA surveillance by the 
viable Csl4 truncations. A. Cytoplasmic mRNA degradation assay of the depicted 
truncations B. nonstop assay of the depicted truncations. 
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Briefly, to completely abolish cytoplasmic mRNA degradation, which is essential, 
both 5’3’ and 3’5’ degradation pathways must be blocked. A strain with a 
temperature sensitive mutation dcp1-2 and a mutation ski4-1 was used. The ski4-1 
mutation blocks the 3’5’ mRNA degradation pathway. The dcp1-2 mutation 
conditionally blocks the 5’3’ mRNA degradation pathway when transferred to non-
permissive temperature. For description of the assay, see Chapter 2 “Materials and 
methods”. The dcp1-2 ski4-1 mutant was transformed with vectors encoding viable 
truncations of Csl4 and then grown at permissive and non-permissive temperatures. 
At the non-permissive temperature both pathways for mRNA degradation are 
blocked and this strain can only survive if a truncation of Csl4 can substitute for the 
mRNA degradation role of wild-type Csl4. As seen in Figure 4-4 A, truncations 
lacking the Zn ribbon-like domain did not survive, while other truncations did, 
indicating that the Zn ribbon-like domain is required for mRNA degradation by the 
exosome. Additionally, the truncations were tested for nonstop mRNA surveillance 
by the exosome. A csl4 strain supplemented by truncations of Csl4 were 
transformed with a vector carrying a HIS3 gene lacking a stop codon (his3-nonstop) 
and grown with and without histidine.  Only the truncations lacking the Zn ribbon-like 
domain grew on medium lacking histidine, indicating that the Zn ribbon - like domain 
is required for nonstop mRNA degradation by the exosome. Therefore, the Zn 
ribbon-like domain of Csl4 is required for all known cytoplasmic roles of the 
exosome. 
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Posttranslational phosphorylaiton at S94 is not important for the essential 
role Csl4. 
   To continue looking into the role of Csl4, a search of PhospoPep and 
PhosphoGRID phosphorylation databases was performed for possible 
phosphorylation sites. It was found that Csl4 could potentially be phosphorylated in 
the linker  between the RPL27-like and the S1 domain, at residue S94 (Synowsky et 
al., 2006).To test if the phosphorylation was required for viability, residue 94 was 
mutated to alanine and to glutamic acid to mimic the phosphor-free and the 
phosphorylated state. Both mutants were able to substitute for the essential role of 
Csl4, indicating that this particular potential posttranslational modification was not 
required for viability (Figure 4-5). 
 
The Zn ribbon-like domain is essential in the absence of the RPL27-like 
domain 
   While expressing the S1 and Zn ribbon-like domains together was sufficient for 
viability, expressing either one by itself was not. To determine which domain, S1 or 
Zn ribbon-like, carried the essential function, 23 conserved amino acids were 
mutated in either the S1 or the Zn ribbon-like domain. All of the mutations were 
created in a truncation of Csl4 which lacks the RPL27-like domain because the 
RPL27-like domain is viable on its own as determined previously. Therefore its 
presence on its own confers viability. All of the amino acids were changed to 
alanine. There were four double mutants in the S1 domain: V210A R211A, D214A  
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Figure 4-5. The posttranslational phosphorylation of Csl4 is not important for the 
essential role Csl4. Plasmid shuffle assay of point mutants of Csl4 S194A and S94E. The 
location of S94 along the Csl4 sequence protein sequence is indicated with an asterisk on 
the picture above.  
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A          B 
 
 
 
 
C              D 
 
 
 
 
Figure 4-6 The Zn ribbon-like domain is essential in the absence of the RPL27-like 
domain. Plasmid shuffle assays of the indicated truncations.  Strain, cls4, is indicated in 
the left  upper corner, the mutations are indicated at the left of each picture, medium 
indicated above the picture of each growth assay A. Point mutants of residues located in 
the S1 domain in truncations lacking the RPL 27 domain. B. Point mutants of residues 
located in the Zn ribbon-like domain. D. Point mutants of residues located in the Zn ribbon-
like domain in truncations with or without the RPL27-like domain C. A Western blot of TAP-
tagged truncation of Csl4 lacking the RPL 27 domain with the indicated point mutations 
above each blot.   
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R215A, D216A R217A, and S236A L237A.  All of these mutants were viable as 
determined by a plasmid shuffle assay (Figure 4-6 A) suggesting that the S1 
domain was not essential for viability. To check if the Zn ribbon-like domain was 
essential for viability, nine mutants were created in the Zn ribbon-like domain: 
D251A L252A, G253A, V254A V255A, M267A, W272A, Y268A T270A W272A, 
M275A P278A, E284A R286A K287A, and K290A. With the exception of W272A 
and K290A, all of the rest of the mutations were lethal (Figure 4-6 B). To confirm 
that the lack of growth was due specifically to the point mutations, and not due to 
lack of expression, the expression of these mutants, except W272A which was 
viable, was confirmed by a Western blot (Figure 4-6 C). Addition of the RPL27-like 
domain to the Y268A T270A W272A mutant, restored viability suggesting that the 
RPL27-like domain and the Zn-ribbon domain may have a functional redundancy for 
the essential role of Csl4 (Figure 4-6 D). Overall, these data indicate that in Csl4 the 
Zn ribbon-like domain is essential in the absence of the RPL27-like domain. 
 
The essential role of the Zn ribbon-like domain in the absence of the RPL27-
like domain overlaps with its role in mRNA degradation and nonstop mRNA 
decay. 
   To determine if the essential role of the Zn ribbon-like domain in the absence of 
the RPL27-like domain was specific to the nuclear exosome, the cytoplasmic 
exosome function was also tested. Each of the nonviable truncations was 
transformed into a double mutant dcp1-2 ski4-1 and after selection for  
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Figure 4-7. Point mutations in the Zn ribbon-like domain are defective in mRNA 
degradation in the absence of RPL 27 domain. A and B. mRNA degradation growth 
assays of the indicated point mutations in the S1+Zn ribbon-like truncation of Csl4. 
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transformants, grown at permissive and non-permissive temperatures. Each of the 
mutants that was not able to substitute for the essential role of Csl4 was also not 
able to substitute for mRNA decay function (Figure 4-7 A and B).  In contrast, the 
mutant that was viable, K290A, was also able to substitute for the mRNA decay 
functions. These results suggest that the essential role that the Zn ribbon-like 
domain carries out in the absence of the RPL27-like domain, overlaps with its 
cytoplasmic roles in mRNA degradation and nonstop mRNA decay. 
 
Localizing the Zn ribbon-like domain to the exosome is not sufficient for the 
essential role of Csl4 
    One possible explanation of the data presented above is that the Zn ribbon-like 
domain has an important function and that the S1 domain may allow it to carry out 
this function by recruiting the Zn ribbon-like domain to the exosome. To test this 
hypothesis, the Zn ribbon-like domain of Csl4 was fused to the N-terminus of Rrp40 
(Zn-Rrp40). The reason for designing the chimera in this manner, versus fusing it to 
the C-terminus, was that the N-terminus of Rrp40 is the domain at which Rrp40 
interacts with the Zn ribbon-like domain of Csl4.Therefore this chimera is expected 
to localize the Zn ribbon-like domain to the site where it is usually positioned on the 
exosome. A vector with the Zn-Rrp40 chimera was transformed into a cl4 strain  
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Figure 4-8 Csl4’s essential role may not be as a part of the exosome complex. A. 
Plasmid shuffle assay of the indicated chimeras in csl4 and rrp40 strains. B. A Western 
blot of Co-immunoprecipitation of Myc-tagged Rrp43 with TAP-tagged Csl4 truncations.   
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and also into an rrp40 strain and after selecting for transformants, both stains with 
appropriate controls were grown on 5FOA for a plasmid shuffle assay. The Zn-
Rrp40 chimera was able to complement an rrp40 strain indicating that the protein 
is expressed (Figure 4-8 A bottom 3 lanes). However, the Zn-Rrp40 chimera was 
not able to complement a csl4 strain, indicating that localizing the Zn domain to the 
exosome was not sufficient for viability (Figure 4-8 A).  
 
Multiple domains contribute to Csl4 association with the exosome 
   Multiple domains were found to be sufficient for viability; however it was not clear 
if each of them was required for localization to the exosome. Therefore, an 
experiment was carried out to test which domain of Csl4 was required for 
localization to the exosome.  TAP-tagged Csl4 truncations were transformed into a 
strain with a Myc-tagged Rrp43.  Co-immunoprecipitation was performed with 
Protein A beads and then a Western blot was performed on the total protein extract 
and the bound fraction. As seen in Figure 4-8 B, Rrp43 only interacted with the full 
length Csl4, but not with any of the other otherwise viable truncations, suggesting 
that these truncations were not interacting with the core exosome. This indicates 
that more than one domain is necessary for the association of Csl4 with the 
exosome. 
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DISCUSSION 
   The data presented in this chapter uncover at least partially the possible roles 
Csl4 may play in the exosome. Given the fact that the other two exosome proteins, 
Rrp4 and Rrp40 were determined to have structural roles, it is interesting that Csl4 
does not seem to bridge PH ring subunits of the exosome. This is despite the fact 
that two of its three domains are very similar and it is also located at the same side 
of the exosome at the RNA entry. Other studies have found that Csl4 is not as 
tightly associated with the exosome as Rrp4 and Rrp40, further supporting the idea 
that it does not stabilize the exosome by bridging interactions, but instead has a 
functional role (Synowsky et al., 2006). The potential phosphorylation site found on 
Csl4 at residue S94 suggests that there may be some regulation, however no effect 
on cell viability was discovered suggesting that regardless of the regulation (if any) 
this modification does not involve the essential role of Csl4. After the conclusion of 
this study a new crystal structure of the exosome was published(Makino et al., 
2013). Therefore the domain organization of Csl4 was revised (Figure 4-9). 
However, the changes to Csl4 were very slight and considering how the truncation 
were made (see Chapter 2, Table 2-2) should not have any effect on the 
conclusions  based on the experiments in this chapter. 
   In addition to its essential and likely nuclear role, Csl4 also has a cytoplasmic role 
and the Zn ribbon-like domain was found to be required for it. A mutant ski4-1, 
which has a point mutation in the Zn ribbon-like domain of Csl4, cannot do 
cytoplasmic mRNA degradation (van Hoof et al., 2000b). However how it exerts its 
effect was not known. This point mutation is only four amino acids away from the S1  
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Figure 4-9. Revised domain organization of Csl4. A. Domain organization of Csl4 
according to the crystal structure published by (Makino et al., 2013). B. Domain orgnizaiton 
of Csl4 used to create the truncations used in this study.  
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domain; therefore it was possible that alteration in the S1 domain, not the Zn ribbon-
like domain was responsible for this effect. The data presented here indicate that it 
is the Zn ribbon-like domain that is required for cytoplasmic mRNA degradation and 
also for nonstop mRNA decay because a truncation lacking the Zn ribbon-like 
domain, but containing the entire S1 domain did affect the cytoplasmic role.  
   A very intriguing finding is that while Csl4 is an essential protein, it does not 
contain a single essential domain. Viability is conferred as long as either the RPL27-
like domain or the S1+Zn domain are expressed. This suggests that whatever the 
essential function of Csl4 is, these two distinct parts of the protein must be able to 
perform it. Each of these two parts of Csl4 interacts independently with the 
exosome. It is therefore possible that a protein cofactor or RNA interact 
independently with separate moieties on Csl4 and when only one or the other is 
expressed there is still residual interaction capable of carrying out the essential 
function of Csl4 (Figure 4-10).  
   Looking to further narrow down which domain of the S1+Zn truncation actually 
carries out the  essential role of this truncation, it was found that in fact it was the Zn 
ribbon-like domain. This conclusion was based on the fact that mutations in 
conserved residues along the Zn ribbon-like domain were inviable, while point 
mutations along conserved residues in the S1 domain did not affect viability.  These 
same mutations also affected the non-essential cytoplasmic roles of Csl4 in normal 
mRNA decay and nonstop mRNA degradation.  
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.  
Figure 4-10. Model for interaction of Csl4 with a protein co-factor or RNA.  A protein 
cofactor or RNA that are required for the essential role of Csl4 interacts with both the 
RPL27-like and the Zn ribbon-like domain and interaction with the exosome is also required 
for viability. On the bottom left is a depiction of the truncations that were sufficient for 
growth and on the bottom right is a depiction of the truncations that were not sufficient for 
growth.  
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One interpretation of these data is that the point mutations of conserved residues 
affect the structure of the Zn ribbon-domain rendering it non-functional. Another 
possibility is that these residues are important for contact and stable interactions 
with a protein cofactor or RNA substrate which are weakened even further in the 
absence of the RPL27-like domain. Finally a combination of these interpretations 
may be what is actually going on and some mutations may affect structure while 
others may affect binding.  Regardless of that, it is the Zn ribbon-like domain that 
overlaps with the RPL27-like domain for the essential role of Csl4. However, the Zn 
ribbon-like domain had to be expressed together with the S1 domain. The S1 
domain is where the S1+Zn interact with the exosome. That is consistent with a 
model in which RNA or protein cofactor(s) bind two separate ends of Csl4 and need 
to be brought to the exosome, and in this case the S1 domain may be fulfilling that 
role.  
   Csl4 may participate in a mixed RNA-protein interaction in addition to binding 
exclusively RNA or proteins. For example archaeal Csl4 is required for interaction of 
the exosome with DnaG in order to improve interaction with A-rich RNAs (Hou et al., 
2013). Csl4 is capable of binding both RNA and protein, Rrp6, on different surfaces 
(Makino et al., 2013). Therefore it is possible that there is more than one essential 
role for Csl4 and it binds RNA for one and proteins for a different essential role.  
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Chapter 5: The exoribonuclease of Rrp44 affects iron response 
 
 
 
 
 
 
Disclaimer: This chapter includes experiments completed by other people. The microarray 
and the calculations of mRNA levels were completed in the laboratory of Dr. Allan 
Jacobson, University of Massachusetts. The PARE analysis was completed in the 
laboratory of Dr. Pamela Green at the University of Delaware. 
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INTRODUCTION 
Structural organization of Rrp44, the catalytic subunit of the RNA exosome 
  
   Rrp44 is the only catalytically active subunit of the exosome (Dziembowski et al., 
2007; Liu et al., 2006). It has a 3’5’ exonuclease activity and an endonuclease 
activity (Dziembowski et al., 2007; Greimann and Lima, 2008; Lebreton et al., 2008; 
Schaeffer et al., 2009; Schneider et al., 2009). All known exosome activities are 
affected in an exonuclease point mutant, but not in an endonuclease point mutant. 
These include nuclear roles such as processing of 5.8S rRNA and snoRNAs and 
degradation of the 5’ ETS of rRNA (Allmang et al., 1999a; Mitchell et al., 1996; van 
Hoof et al., 2000a). In addition,  cytoplasmic degradation of normal mRNAs also 
seems to be affected only in the exoribonuclease mutant (Schaeffer and van Hoof, 
2011). In the case of cytoplasmic nonstop mRNA degradation the exonuclease and 
the endonuclease domains are redundant, but still, there is no known substrate that 
is specific only to the endonuclease (Schaeffer and van Hoof, 2011) 
   Rrp44 has 5 domains. From the N to the C terminus the domain organization is as 
follows: there is a PIN domain which harbors the endonuclease activity, two cold 
shock (CSD)  domains CSD1 and CSD2, an RNB domain which has the 3’5’ 
exoribonuclease activity, and an S1 domain which is an RNA binding domain 
(Figure 5-1). In addition, at the very N-terminus of the protein there is a conserved 
region of 33 amino acids followed by a CR3 region which consists of three 
conserved cysteine residues (Cairrao et al., 2005; Schaeffer et al., 2012). Each of 
the domains of Rrp44 is found both in eukaryotic and prokaryotic organisms and 
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with the exception of the PIN domain, the rest of the domains are shared between 
Rrp44 and its bacterial homologues RNase II and RNase R (Amblar et al., 2006; 
Vincent and Deutscher, 2009).  Point mutants are available that completely 
inactivate the catalytic activities of the exosome. A point mutation D171A completely 
abolished the endonuclease activity (Schaeffer et al., 2009), while a point mutant 
D551N eliminates the 3’5’ exoribonuclease activity (Dziembowski et al., 2007).  
  Rrp44 contacts the exosome at the site opposite of the RNA binding proteins (see 
Chapter 1, Figure 1-1). RNA that is threaded through the PH ring reaches the RNB 
domain of Rrp44 where it is hydrolytically degraded in the 3’5’ direction. The 
exonuclease faces the central channel and thus any substrate that emerges from it, 
suggesting that RNA that goes through the channel is destined for exoribonuclease 
degradation. It is not clear however why the endonuclease faces away from the 
central channel (Chapter1, Figure 1-1). Studies suggest that the RNA is delivered to 
the endonuclease through the central channel as well,  since mutations in the 
central channel were shown to affect the activity not only of the exonuclease, but 
also of the endonuclease (Drazkowska et al., 2013; Wasmuth and Lima, 2012) 
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Figure 5-1. Domain organization of Rrp44. The domains of Rrp44 are depicted. 
Locations of the nuclease point mutants are shown above the protein and the part of Rrp44 
that is homologous to RNase II and RNase R is shown below the protein.  
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   While Rrp44 is the only catalytic subunit of the eukaryotic exosome, it may not 
always be associated with the exosome. For example, there are three proteins that 
are homologues of Rrp44 in humans, and they localize to different cellular 
compartments (Tomecki et al., 2010). In S. cerevisiae and in Drosophila 
melanogaster Rrp44 is not as tightly associated with the exosome as the rest of the 
subunits (Allmang et al., 1999b; Graham et al., 2009a). An Rrp44 mutant that has 
the N-terminus deleted does not associate with the exosome (Schneider et al., 
2009). Studies in Arabidopsis thaliana and in trypanosomes did not find that Rrp44 
associates with the exosome, however it is still possible that in vivo Rrp44 does in 
fact associate with the exosome in these organisms (Chekanova et al., 2002; 
Estevez et al., 2001). Finally, microarray studies on knock downs of Rrp44, Rrp6, 
and core exosome subunits, showed that the substrates of each differed suggesting 
again exosome independent roles for these proteins (Kiss and Andrulis, 2010). 
Regardless of whether it does or it doesn’t have exosome independent functions, 
Rrp44 does provide the catalytic activity of the exosome thus it is important for all of 
the exosome’s functions.  
 
Functional studies of Rrp44 and the exosome 
   Most studies of the exosome and Rrp44 have concentrated on substrate 
specificities and structure, thus functional studies are limited. However there are 
several studies that associate the exosome and Rrp44 with particular cellular roles. 
Rrp44 has been found to alter circadian rhythm in Neurospora crassa (Guo et al., 
2009). Yeast Rrp44 mutant has also been found to have a defect in microtubules 
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(Smith et al., 2011). Finally, a study showed that Rrp44 affects chromosome 
segregation and mitotic progression in Schizosaccharomyces pombe  by affecting 
kinetochore formation and kinetochore-microtubule interactions (Murakami et al., 
2007).  
 
Iron response in S. cerevisiae 
   Iron balance is critically important for the cell, because iron is on the one hand an 
essential element required for the production of all proteins with an iron-sulfur 
cluster, but on the other hand too much free iron is toxic. Therefore the intake of 
iron is tightly regulated (Figure5-2).  
   It is not known how low iron is sensed, however an inhibitory signal is known to 
come from the mitochondria and to be dependent on the mitochondrial transporter 
Atm1 (Rutherford et al., 2005). This in turn downregulates the glutathione 
reductases Grx3 and Grx4 which promote export from the nucleus of the major iron 
response regulator Aft1 by forming a complex with Fra1/2 and stimulating Aft1’s 
dimerization (Li et al., 2009; Pujol-Carrion et al., 2006). When Aft1 dimerizes, it is 
expelled form the nucleus and thus cannot activate transcription of the iron 
response genes (Ojeda et al., 2006; Yamaguchi-Iwai et al., 2002). 
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Iron replete conditions: 
 
Iron deplete conditions: 
 
 
Figure 5-2 Activation of iron response in S. cerevisiae. During iron replete conditions an 
unknown inhibitory signal is translocated from the mitochondrial transporter Atm1. This 
stimulates Grx3 and Grx4 to induce Aft1 dimerization and subsequent export out of the 
nucleus. During iron replete conditions there is no signal form the mitochondria, thus no 
Grx3/4 induced Aft1 dimerization and the monomeric Aft1 remains in the nucleus and binds 
to Aft1 binding site (Aft1 BS) in the promoters of genes of the iron regulon. Blue circle – 
nucleus, yellow circle – vacuole, light purple oval – mitochondrion. 
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When Grx3 and Grx4 are not available to bind Aft1 and facilitate its export into the 
cytoplasm, the monomeric Aft1 remains in the nucleus and binds to promoters with 
a specific Aft1 binding site to activate transcription. The genes activated by Aft1 are 
collectively called the iron regulon.   
   The iron regulon includes three different classes of genes, which are further 
regulated depending on the cellular responses.  Activation of Aft1 leads first to 
upregulation of the iron intake mechanisms; second, the cell switches, wherever 
possible, to iron independent pathways; third, iron stored in the vacuole is released. 
These events occur in the order listed here and if one is sufficient to overcome the 
iron deficiency then the next does not take place (Philpott and Protchenko, 2008).  
 
   To determine the primary activity of the exosome I have looked at the 
exonuclease and endonuclease activities independently. I used rrp44-exo- and 
rrp44-endo- mutants to look at the effects they have on known exosome substrates, 
growth rate, and gene expression. Additionally, in collaboration with Pamela 
Green’s lab from University of Delaware, I tried to identify specific substrates of the 
endonuclease. Data presented in this chapter show that the primary activity of the 
exosome is the exoribonuclease and that a major consequence of inactivating the 
exoribonuclease is the activation of iron response.   
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RESULTS 
The primary activity of Rrp44 is in the exoribonuclease 
   Since the exosome has both an exonuclease and an endoribonuclease, it is 
unclear which activity if important for which roles of the exosome. To test which 
activity is important for growth, point mutants of either the exonuclease, D551N 
(rrp44-exo-), or the endonuclease, D171A (rrp44-endo-), were transformed into an 
rrp44 strain and were grown for twenty four hours in liquid YPD medium. Growth 
was only affected in the exonuclease but not in the endonuclease mutant indicating 
that the exonuclease is important for growth under standard lab conditions (Figure 
5-3).  
   Additionally, a deep sequencing of internally cleaved RNA fragments was 
concluded with the help of Pamela Greens’ lab at the University of Delaware, 
searching for products specific to the endonuclease (Figure 5-4). Parallel analysis of 
RNA ends (PARE) was used to construct libraries of cleavage products of wild type 
and rrp44-endo- mutant (German et al., 2009). Briefly, RNA was isolated from wild 
type and rrp44-endo- and polyadenylated RNA was purified. Next, an adapter 
specific to a 5’ phosphate and with a MmeI restriction enzyme binding site was 
ligated to the 5’ of the RNA. The adapter ligation was followed by reverse 
transcription (Figure 5-4) and then a second DNA strand was synthesized. The 
resulting dsDNA was then cleaved with MmeI. MmeI one cleaves 20 bp away from 
the MmeI site therefore the resulting 20 bp fragments captured the site of the 
internal cleavage and 13 bp downstream.  
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Figure 5-3 Growth is affected only in the exonuclease but not in the endonuclease 
mutant. A growth curve representing average of three independent clones for 24 hrs 
growth in liquid YPD medium. Green is wild-type, red - rrp44-exo-, and orange - rrp44-endo-
.    
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Figure 5-4. Selection of internally cleaved products for deep sequencing. Step 1- 
polyadenylated RNA is isolated. Cleavage products are expected to have a 5’ phosphate to 
which an adaptor with MmeI recognition site is ligated. Step 2- the RNA is reverse 
transcribed and PCR amplified for a second strand synthesis; Step3- Digestion with MmeI 
which cuts 20bp away from its recognition site; Step 4- A 3’ adaptor is ligated to the 20bp 
signature reads; Step 5- The sequences are PCR amplified and sequenced.  
This figure is based on (German et al., 2009)  
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Two wild-type libraries and one rrp44-endo- library were constructed. The 
sequencing generated 1 282 573 20 bp unique reads that matched to the genome. 
Fragments smaller than 20 bp were not detected. All identified mRNAs had less 
than 5x increase in rrp44-endo- compared to wild type suggesting that the 
degradation of any particular mRNA is not controlled by  the endonuclease. Thirteen 
candidate genes were identified based on PARE signatures that were present in the 
wild-type libraries but not present in the rrp44-endo- mutant. Of these the best three 
candidates were CAF20, REV1, and a dubious ORF YMR304C-A (Figure 5-5 A). 
Northern blots for REV1, and YMR304C-A were unable to detect these RNAs. The 
levels of the CAF20 mRNA showed no difference between wild-type and rrp44-
endo- on a Northern blot (Figure 5-5 B). Two tRNA genes were also a part of the 
gene set of the thirteen candidates – tRNA-Asp (tRNA(GUC)L1) and tRNA-Glu 
(tRNA(CUC)D). Northern blots of these two tRNAs also showed no differences in 
the levels of these transcripts between wild-type and rrp44-endo- strains (Figure 5-5 
C).The  tRNA Asp identified in the PARE analysis is initially synthesized as a 
dicistronic transcript together with tRNA Arg and then the transcript is cleaved by 
RNase P which also cleaves the 5’ ends of other tRNA transcripts (Engelke et al., 
1985; Schmidt et al., 1980). Therefore Northern blots were also probed for these 
two transcripts. Neither tRNA-Arg-Asp nor RNase P showed any difference in 
transcript levels between wild type and rrp44-endo-. Based on these analyses it was 
concluded that no specific substrates for the endonuclease activity of Rrp44 were 
identified using the PARE analysis method. 
  
 
 
 
106 
 
 
 
 
 
Figure 5-5 PARE analysis did not identify specific substrates for the endonuclease of 
Rrp44. A. Plots of the three best candidate genes. YOR276W= CAF20, YOR346W=REV. 
SCE291 (green) is the library from the rrp44-endo- strain. SCE02 (blue) and SCE290 (red) 
are libraries form the wild-type strain. B. Northern blot analysis of CAF20 mRNA in wild-type 
(WT) and rrp44-endo- strains. C. Northern blot analyses of tRNAGlu, tRNAAsp, RNase P, 
and tRNA-Arg-Asp (polycistronic) transcripts.  
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   A microarray analysis of poly(A) RNA from rrp44-exo- and  rrp44-endo- also did 
not find any effects on gene expression for the endoribonuclease (for details on the 
microarray see the sections below).  
   Therefore, considering that the endonuclease does not affect known exosome 
roles and growth phenotype, that the deep sequencing of  cleavage products failed 
to identify specific endonuclease products, and a microarray failed to identify effects 
on gene expression, it was concluded that the primary activity of Rrp44 is carried 
out by the exonuclease.  
 
Iron response is activated in rrp44exo- mutant  
   To characterize the effects the endoribonuclease or the exoribonuclease activity 
of Rrp44 have on gene expression, poly(A) RNA was isolated from wild-type, rrp44-
exo- , and rrp44-endo-  strains and  hybridized to a Affymetrix  S. cerevisiae / S. 
pombe tiling microarray. Hybridization and initial analysis were done by the Allan 
Jacobson’s Lab at the University of Massachusetts Medical School. The RNA was 
isolated in quadruplicate and mRNAs that were upregulated at least two-fold were 
selected for further analysis. No mRNAs were affected in the rrp44-endo- mutant, 
however 84 mRNAs were upregulated and 63 were downregulated in the rrp44-exo- 
(Table 5-1 and Table 5-2) 
 
   To assess if there was enrichment of any particular cellular processes, a gene 
ontology (GO) analysis was used. The main GO terms that were identified were all 
 
 
 
108 
 
related to iron uptake. Altogether, 10 of the 84 mRNAs (12%) were directly 
implicated in iron uptake. To verify the microarray results, a Northern blot was 
completed with FIT2 and TIS11 probes (Figure 5-6). In addition, RNA was isolated 
from an independently created rrp44-exo- mutant and the same RNAs was analyzed 
by a Northern blot. Increase in FIT2 and TIS11 mRNAs was noted in both the 
original and the independently created strain, thus it was concluded that the 
upregulation of iron response is a major physiological response in rrp44-exo-. 
 
Iron response in the rrp44-exo- is activated by activation of Aft1 
   Since a mutant that is defective specifically in RNA degradation (rrp44-exo-) was 
used for the microarray, there were two possibilities for the increased abundance of 
the iron regulon mRNAs. First, the exonuclease could be degrading these mRNAs 
which would lead to their increase in an exonuclease mutant. Second, the increase 
may be secondary to some other effect caused by the exonuclease which leads to 
activation of the transcription factor responsible for activating transcription of these 
mRNAs. Aft1 is the transcription factor that is the major factor responsible for 
regulating iron response. Aft1 has been shown to bind to a ANTGCACCC elements 
in promoters of Aft1-regulated genes and stimulate transcription (Yamaguchi-Iwai et 
al., 1996). 
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Table 5-1 Microarray data – genes upregulated at least twofold in all four samples 
Gene Fold 
elevation 
Aft1 
BS 
Synonym Description 
  9.61   YDR042C ORF, Uncharacterized 
  8.47   YKL183C-A ORF, Uncharacterized 
FIT2 7.73 yes YOR382W siderophore-iron transporter 
  6.78   YHR022C-A ORF, Uncharacterized 
  5.93   YHR214C-E ORF, Uncharacterized 
  5.73   YGR121W-A ORF, Uncharacterized 
FIT3 5.51 yes YOR383C Siderophore-iron transporter 
  5.50   YAR075W Nonfunctional protein 
TIS11 5.47 yes YLR136C mRNA-binding protein expressed during iron 
starvation 
ECM12 5.25   YHR021W-A ORF, Uncharacterized 
PRM6 5.07   YML047C Pheromone-regulated protein 
  4.74   YML007C-A ORF, Uncharacterized 
SIT1 4.73 yes YEL065W Transporter of siderophore-iron chelates 
  4.26   YBR298C-A ORF, Uncharacterized 
  4.13   YAL064W Protein of unknown function 
  4.09   YOR394C-A ORF, Uncharacterized 
FIG1 3.98   YBR040W Integral membrane protein required for efficient 
mating 
  3.98   YOL155W-A ORF, Uncharacterized 
  3.89   YMR001C-A ORF, Uncharacterized 
AGA2 3.88   YGL032C Adhesion subunit of a-agglutinin of a-cells 
DIP5 3.88   YPL265W Dicarboxylic amino acid permease 
GRE1 3.87   YPL223C Stress induced hydrophillin  
  3.86   YOL097W-A ORF, Uncharacterized 
  3.82   YHR214C-D ORF, Uncharacterized 
ARN1 3.79 yes YHL040C Transporter of siderophore-iron chelates 
  3.72   YLL066W-B ORF, Uncharacterized 
HMX1 3.69 yes YLR205C ER localized, heme-binding peroxidase 
NRD1 3.67   YNL251C nuclear RNA-binding protein 
  3.59   YBR296C-A ORF, Uncharacterized 
  3.57   YGR204C-A ORF, Uncharacterized 
SET6 3.46   YPL165C Protein of unknown function 
ARP10 3.39   YDR106W Component of the dynactin complex 
  3.37   YOL162W ORF, Uncharacterized 
PDH1 3.29   YPR002W Mitochondrial protein that participates in 
respiration, induced by diauxic shift 
  3.29   YOR032W-A ORF, Uncharacterized 
  3.24   YNL277W-A ORF, Uncharacterized 
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Table 5-1 ( continued)  Microarray data – genes upregulated at least twofold in all four 
samples 
 
Gene Fold 
elevation 
Aft
1 
BS 
Synonym Description 
PRM5 3.21   YIL117C Pheromone-regulated protein 
  3.17   YCR108C ORF, Uncharacterized 
HUG1 3.16   YML058W-A Protein involved in the Mec1p-mediated 
checkpoint pathway 
VMR1 3.13   YHL035C Vacuolar membrane protein 
  3.11   YGR035C ORF, Uncharacterized 
MAL33 3.09   YBR297W MAL-activator protein 
ARN2 3.09 yes YHL047C Transporter of  siderophore-iron chelates 
FRE2 3.07 yes YKL220C Ferric  and cupric reductase 
PRM2 3.05   YIL037C Pheromone-regulated protein 
CUE2 3.05   YKL090W Protein of unknown function 
TAD2 3.02   YJL035C Subunit of tRNA-specific adenosine-34 
deaminase 
IMD1 ; 
IMD2 
3.00   YAR073W Nonfunctional protein with homology to IMP 
dehydrogenase 
HES1 2.98   YOR237W Protein implicated in the regulation of ergosterol 
biosynthesis 
TIR4 2.96   YOR009W Cell wall mannoprotein  
ALP1 2.94   YNL270C Basic amino acid transporter 
NCA3 2.92   YJL116C Protein involved in mitochondrial organization 
  2.92   YOL163W ORF, Uncharacterized 
COS12 2.87   YGL263W Protein of unknown function 
MIG2 2.87   YGL209W Zinc finger transcriptional repressor 
  2.81   YER078W-A ORF, Uncharacterized 
CIN1 2.77   YOR349W Tubulin folding factor D 
RKM5 2.76   YLR137W Protein lysine methyltransferase 
FUS2 2.74   YMR232W Cytoplasmic protein localized to the shmoo tip 
FYV5 2.72   YCL058C Protein involved in regulation of the mating 
pathway 
MND1 2.71   YGL183C Protein required for recombination and meiotic 
nuclear division 
  2.69   YLR108C Protein on unknown function 
AYT1 2.68   YLL063C Acetyltransferase 
FLO1 2.67   YAR050W Lectin-like protein involved in flocculation 
ZPS1 2.67   YOL154W Putative GPI-anchored protein 
  2.65   YOL114C ORF, Uncharacterized 
FET3 2.60 yes YMR058W Ferro-O2-oxidoreductase 
ARG82 2.57   YDR173C Protein involved in regulation of arginine-
responsive and Mcm1p-dependent genes 
  2.56   YNL024C ORF, Uncharacterized 
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Table 5-1 ( continued)  Microarray data – genes upregulated at least twofold in all four 
samples 
 
Gene Fold 
elevation 
Aft
1 
BS 
Synonym Description 
  2.52   YLR412C-A ORF, Uncharacterized 
  2.48   YJL136W-A ORF, Uncharacterized 
MIG3 2.46   YER028C Transcriptional regulator;  role in catabolite 
repression and ethanol response 
ENB1 2.45 yes YOL158C Endosomal ferric enterobactin transporter 
RRN3 2.44   YKL125W Protein required for transcription of rDNA by RNA 
polymerase I 
  2.44   YJL027C ORF, Uncharacterized 
  2.40   YGR146C-A ORF, Uncharacterized 
CCC2 2.39   YDR270W Cu(+2)-transporting P-type ATPase 
DAN3 2.30   YBR301W Cell wall mannoprotein 
  2.30   YIL089W Protein of unknown function 
MTC3 2.27   YGL226W Protein of unknown function 
PCK1 2.26   YKR097W Phosphoenolpyruvate carboxykinase 
AIM4 2.12   YBR194W Protein proposed to be associated with the 
nuclear pore complex 
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Table 5-2 Microarray data- genes downregulated at least twofold in all four samples 
 
 
Gene  Fold 
elevation 
Synonym Description 
ARO10 0.05 YDR380W Phenylpyruvate decarboxylase 
GYP5 0.06 YPL249C GTPase-activating protein (GAP) for yeast Rab family 
members, involved in ER to Golgi trafficking 
ARO9 0.16 YHR137W Aromatic aminotransferase 
INH1 0.17 YDL181W Protein that inhibits ATP hydrolysis by the F1F0-ATP 
synthase 
GRX4 0.18 YER174C Monothiol glutaredoxin 
MGA1 0.20 YGR249W Protein similar to heat shock transcription factor 
PHM6 0.22 YDR281C Protein of unknown function 
HFM1 0.25 YGL251C Meiosis specific DNA helicase 
YFH7 0.25 YFR007W Putative kinase 
SPO1 0.26 YNL012W Meiosis-specific protein 
LIN1 0.26 YHR156C Non-essential component of U5 snRNP 
HXT7 ; 
HXT6 
0.26 YDR342C High-affinity glucose transporter 
ISF1 0.27 YMR081C Serine-rich, hydrophilic protein 
PHO89 0.27 YBR296C Na+/Pi cotransporter, active in early growth phase 
NRT1 0.27 YOR071C High-affinity nicotinamide riboside transporter 
SPL2 0.28 YHR136C Protein with similarity to cyclin-dependent kinase inhibitors 
  0.28 YNL040W ORF, Uncharacterized 
GMC1 0.29 YDR506C Protein involved in meiotic progression 
PHO5 0.30 YBR093C Repressible acid phosphatase 
FMP48 0.30 YGR052W ORF, Uncharacterized 
CYB2 0.31 YML054C Cytochrome b2 
LAP4 0.31 YKL103C Vacuolar aminopeptidase 
TIR1 0.31 YER011W Cell wall mannoprotein , expression is downregulated at 
acidic pH  
COX4 0.31 YGL187C Subunit IV of cytochrome c oxidase 
  0.31 YKL151C NADHX dehydratase 
DDR48 0.33 YMR173W DNA damage-responsive protein 
TAX4 0.34 YJL083W Protein involved in regulation of phosphatidylinositol 4,5-
bisphosphate concentrations 
TPO4 0.34 YOR273C Polyamine transport protein 
  0.34 YPL113C Glyoxylate reductase 
AGP1 0.34 YCL025C Low-affinity amino acid permease,, involved in uptake of 
asparagine, glutamine, and other amino acids 
  0.34 YNL134C Protein of unknown function 
EDS1 0.34 YBR033W ORF, Uncharacterized 
TIR3 0.35 YIL011W Cell wall mannoprotein  
  0.35 YHR202W ORF, Uncharacterized 
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Table 5-2 (continued) Microarray data- genes downregulated at least twofold in all four 
samples 
Gene  Gene  Gene  Gene  
CYT1 0.36 YOR065W Cytochrome c1 
HSP30 0.36 YCR021C Hydrophobic plasma membrane protein 
GDH1 0.37 YOR375C NADP(+)-dependent glutamate dehydrogenase 
CYC1 0.38 YJR048W Cytochrome c, isoform 1 
ARG1 0.38 YOL058W Arginosuccinate synthetase 
GGC1 0.38 YDL198C Mitochondrial GTP/GDP transporter 
CUE5 0.38 YOR042W Protein containing a CUE domain that binds ubiquitin 
ALD5 0.38 YER073W Mitochondrial aldehyde dehydrogenase 
RTC3 0.38 YHR087W Protein involved in RNA metabolism 
ARG3 0.39 YJL088W Ornithine carbamoyltransferase 
VTC3 0.39 YPL019C Vacuolar membrane protein 
GPH1 0.39 YPR160W Glycogen phosphorylase required for the mobilization of 
glycogen 
GAD1 0.40 YMR250W Glutamate decarboxylase 
CSR2 0.40 YPR030W Nuclear protein with a potential regulatory role in utilization of 
galactose and nonfermentable carbon sources 
PHO11 ; 
PHO12 
0.40 YAR071W One of three repressible acid phosphatases, a glycoprotein 
that is transported to the cell surface 
  0.40 YPL014W ORF, Uncharacterized 
GSY1 0.41 YFR015C Glycogen synthase  
WSC4 0.41 YHL028W ER membrane protein 
RIP1 0.42 YEL024W Ubiquinol-cytochrome-c reductase, a Rieske iron-sulfur 
protein of the mitochondrial cytochrome bc1 complex 
ARG5,6 0.42 YER069W Protein that is processed in the mitochondrion to yield 
acetylglutamate kinase and N-acetyl-gamma-glutamyl-
phosphate reductase, which catalyze the 2nd and 3rd steps 
in arginine biosynthesis 
  0.42 YJR129C ORF, Uncharacterized 
TFB6 0.42 YOR352W Subunit of TFIIH complex 
CPA2 0.43 YJR109C Large subunit of carbamoyl phosphate synthetase 
RIP1 0.43 AFFX-r2-Sc-
RIP1-M 
Ubiquinol-cytochrome-c reductase, a Rieske iron-sulfur 
protein 
MNN1 0.44 YER001W Integral membrane glycoprotein of the Golgi complex 
HXT4 0.44 YHR092C High-affinity glucose transporter of the major facilitator 
superfamily 
COR1 0.45 YBL045C Core subunit of the ubiquinol-cytochrome c reductase 
complex (bc1 complex) 
MEP1 0.45 YGR121C Ammonium permease 
SMF1 0.46 YOL122C Divalent metal ion transporter  
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Figure 5-6 Verification of microarray results. A Northern blot with probes for FIT2 and 
TIS11 in wild-type (WT) and rrp44-exo-. The numbers in parenthesis indicated the fold 
elevation in the microarray. SRP is the RNA part of the signal recognition particle, used for 
loading control. 
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Each of the iron response genes that were upregulated in the microarray had a 
binding site for Aft1 in its promoter region. These data suggested that rrp44-exo- 
may cause Aft1 activation, which in turn would increase the transcription of the iron 
response mRNAs. 
   To test whether Aft1 was activated, two assays were conducted. First, an indirect 
lacZ based assay was completed. Briefly, a lacZ reporter gene with a minimal CYC1 
promoter and an Aft1 binding site was constructed. As a control, the same vector, 
but without the Aft1 site was used. The reporter plasmids were transformed into 
wild-type and rrp44-exo- strains and a beta-galactosidase activity assay was carried 
out.  Beta-galactosidase levels were increased 2.1 fold in the rrp44-exo- strain 
compared to the wild-type strain (Figure 5-7 A). In addition, when comparing only 
the levels of the control reporter, without the Aft1 binding site, in wild type versus 
rrp44-exo-, these levels were not significantly different (Figure 5-7 B). This indicates 
that rrp44-exo- does not affect the level of the reporter itself. To directly observe 
Aft1 localization a construct with GFP-tagged Aft1 was transformed into an rrp44-
exo- strain and in wild-type strain. Aft1 was observed to be localized in the nucleus 
in 44% of the cells, while only in 15% of the wild-type cells, which is consistent with 
it being activated in the rrp44-exo- mutant (Figure 5-8).   
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 n=3 
 
 
 
 
 
 
B                                                    
 
 
        
n=3 
 
 
 
 
 
Figure 5-7 Aft1 is activated in rrp44-exo-. A. Beta-galactosidase activity of wild-type and 
rrp44-exo- transformed with a reporter with either Aft1 binding site or without (vector). The 
data is averaged of 3 experiments and normalized to wild-type.  B. A close-up views of the 
wild-type versus rrp44-exo- transformed with only the reporter. This is the same data as 
above, but normalized to the wild-type + vector strain.  
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   Taken together these data suggest that the increased levels of iron regulon 
mRNAs was not directly caused by the exonuclease by means of these mRNAs not 
being degraded, but due to activation of Aft1. Therefore the exonuclease indirectly 
affects the activation of iron response in S. cerevisiae.  
    
The iron response activation in rrp44-exo- is not due to aberrant ATM1 
expression 
   The inhibitory signal for the activation of iron response is known to be dependent 
of the mitochondrial transporter Atm1.To test whether Atm1’s expression was 
affected in the rrp44-exo- mutant, a Northern blot was completed with probe for 
ATM1.  ATM1 was not affected in the microarray and as seen in Figure 5-9 there 
were no differences in the expression of ATM1 in wild type and the rrp44-exo- 
mutant. This suggests that the improper iron activation is not due to an aberrant 
mitochondrial signaling event. One of the regulators of Aft1, Grx4, was one of the 
downregulated mRNAs in the microarray; however numerous attempts to detect 
GRX4 by Northern blots or RT PCR failed, thus the microarray down regulation 
could not be verified.    
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Figure 5-8. Aft1 localizes to the nucleus in higher percentage of rrp44-exo- cells than 
in wild-type cells. Fluorescent microscopy of wild-type and rrp44-exo- cells transformed 
with Aft1-GFP reporter.   
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Figure 5-9. The levels of ATM1 are the same in wild type and rrp44-exo-. Northern blot 
with probes for ATM1 and SRP (loading control) in wild-type (WT) and rrp44-exo-. 
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DISCUSSION 
 
   This chapter examines the importance of the different ribonuclease domains of 
Rrp44 and their effect on gene expression.  I have shown that the primary activity of 
Rrp44 is in the exoribonuclease domain. In addition I have determined that a major 
consequence of the exonuclease inactivation is the indirect activation of iron 
response. 
   Interestingly, I was unable to find any specific substrates for the endonuclease 
and there was no effect of gene expression in the rrp44-endo- mutant as determined 
by the microarray analysis. These data are consistent with the data that rrp44-endo- 
also does not have a growth phenotype and with other studies that also were 
unable to find substrates for the endonuclease (Schneider et al., 2012). However, 
knockouts of the endonuclease and exonuclease of Rrp44 are synthetically lethal. 
Therefore for the essential role of Rrrp44, the endonuclease overlaps with the 
exonuclease. The data presented here suggest that all of the endonuclease 
substrates are also substrates for the exonuclease, while the opposite is not true. It 
is possible that for the most critical substrates, the ones that cause the synthetic 
lethality phenotype, the exosome has developed a back-up system by using two 
separate active sites to ensure their degradation or processing.  It would be 
interesting to find out what the effect on gene expression is in a knock-out of both 
enzymatic activities on Rrp44. However, since a double mutant is inviable such an 
experiment inherently has certain limitations. For example, it can only be done 
shortly after knocking out both enzymatic activities possibly not giving it enough 
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time for major changes to occur. Yet, it would be interesting to determine if new 
substrates, not affected in the single mutant, emerge from such a screen. 
 
   Activation of iron response seems to be a major consequence of the inactivation 
of the exonuclease. Therefore, in the wild-type strain, the exonuclease actually 
functions as a negative regulator of iron response.  Iron response is a very 
complicated process which includes various control points. For example, if iron is 
low, iron importers are upregulated and iron is imported into the cell. However, if the 
influx of iron is still not sufficient, then a reorganization of metabolic processes take 
place to include enzymes that are iron independent and if the influx of iron is 
sufficient then this metabolic reorganization does not occur. Yet another check point 
exists, in the case when the influx of iron and the metabolic reorganization are still 
not sufficient, the iron stored in the cellular vacuole is released. Therefore even 
when the major regulator of iron response Aft1 is activated, there are more 
checkpoints downstream of it to ensure the correct response is carried out.  The 
exonuclease of Rrp44 seems to function on the initial response to iron deprivation, 
because neither genes for metabolic reorganization, nor vacuolar genes involved in 
iron response were affected in rrp44-exo-.  
   Two of the three total functional studies of Rrp44 have found a connection 
between microtubules and Rrp44 (Murakami et al., 2007; Smith et al., 2011). Here, I 
find that the major transcription factor of iron response is activated in rrp44-exo-. 
Interestingly, Aft1 was recently found to interact with kinetochore proteins (Hamza 
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and Baetz, 2012). It would be interesting to find out if a connection between these 
two phenotypes, Aft1 activation and kinetochore-microtubule defects, exists. 
   It was surprising to find out that the effect on gene expression was relatively 
modest, with 84 upregulated and 63 downregulated mRNAs. Since the exosome is 
an exoribonuclease, the downregulated mRNAs were certainly indirectly affected 
and in addition I determined that for at least the 10 iron response mRNAs, the effect 
was also indirect. The fact that there is so much indirect effect can be explained by 
the fact that the essential role of Rrp44 is in the nucleus, while in the cytoplasm the 
role of the exosome in mRNA degradation overlaps with that of the enzymes from 
the 5’3’ mRNA degradation  pathway. Therefore, any effect on gene expression 
that is exosome specific is more likely to be affected by the nuclear exosome, thus 
most likely to be indirect.  
   Another cytoplasmic role for the exosome is the degradation of aberrant nonstop 
mRNAs. This role is independent of the 53’ degradation pathway, thus it is 
exosome specific. However, it is not likely that the mRNAs seen in the microarray 
are the results of lack of nonstop mRNA degradation, because for that role the 
exonuclease and the endonuclease were shown to be redundant (Schaeffer and 
van Hoof, 2011). In the strains used for the microarray, rrp44-exo- and rrp44-endo-, 
there is always either exonuclease or endonuclease activity of Rrp44 which would 
rapidly degrade such mRNAs therefore they would not be detected by the 
microarray. 
   Again, as with the lack of identified substrates for the endonuclease, one possible 
explanation for the modest effect on gene expression is the possible overlap of 
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degradation or processing roles between the exonuclease and the endonuclease for 
the most critically important substrates. The nucleus is the location where the 
exosome’s role is essential. In human cells only the Rrp44 homologue that localizes 
to the nucleus has retained an endonuclease activity (Tomecki et al., 2010). This is 
consistent with the idea that the two activities may overlap for the most critical 
substrates.  
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Chapter 6: The exoribonuclease of Rrp44 affects glucose fermentation and 
production of reactive oxygen species  
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INTRODUCTION 
Iron metabolism and oxidative stress in S. cerevisiae  
   Iron is an essential element needed for the activity of many enzymes. Due to the 
high reduction potential of the Fe3+/Fe2+ pair, iron is a part of several proteins in 
the electron transport chain (ETC). In the ETC iron is found as a part of iron-sulfur 
proteins where it is a part of iron-sulfur clusters. It is also found in cytochromes, 
where it is contained in their heme groups. The purpose of the ETC is to build 
proton gradient to be used as energy for the ATP synthase (for a detailed review of 
the ECT in yeast, refer to de Vries and Marres, 1987; Schagger, 2002). Oxidation of 
NADH and FADH2 however requires the initial transfer of protons together with 
electrons. As H2 atoms are transported across the membrane they are oxidized and 
H+ is pumped across the membrane, while electrons are shuttled via the rest of the 
ETC to the terminal electron acceptor, in this case oxygen (Becker et al., 2003). Iron 
in the iron-sulfur clusters receives electrons one at a time, as the protons are 
pumped through the membrane (Becker, Kleinsmith et al. 2003). Therefore iron is a 
critical element for the establishment of proton gradient in the mitochondrial 
intermembrane space and consequently for the cellular ability to produce ATP 
(Figure 6-1). 
   However, as essential as iron is for respiration, it is also important to be kept in 
balance. If iron is in excess and is not sequestered either in the vacuole or as a part 
of a protein, free iron can cause the formation of reactive oxygen species (ROS). 
ROS are constantly produced during normal cellular processes and are also 
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Figure6-1. The electron transport chain (ETC) of S. cerevisiae. S. cerevisiae does not 
have complex I, instead NADH from the TCA cycle is oxidized by the NADH oxidases Nde1 
and Nde2. FADH2 from the TCA cycle is oxidized by Complex II. The NADH oxidases and 
complex II each transfer electrons to Ubiquinone(Ub), a mobile electron carrier, which in 
turn transfers them to the bc1 complex (also called complex III). From the bc1 complex, 
electrons are transferred to another shuttle molecule. Cytochrome C. Cytochrome C 
shuttles the electrons to Cytochrome C oxidase (COX) also called complex 4, which in turn 
transfers them to the terminal electron acceptor oxygen. As electrons are transferred, 
protons are pumped through the inner mitochondrial membrane into the intermembrane 
space and the proton gradient that is created is used by the ATP synthase to make ATP 
from ADP and inorganic phosphate. The two places where electrons leak from the ETC are 
at the Nde1/2 and the bc1 complex. If excess free iron is available, reactive oxygen species 
(ROS) are formed.    
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constantly detoxified. Damage caused by ROS is also constantly repaired, and in 
the event of oxidative stress, the cell responds by a series of events collectively 
called the oxidative stress response. 
 
Location and timing of production of ROS in S. cerevisiae 
   The mitochondrial membrane is the main location of ROS production. This is due 
to electrons escaping the ETC during respiration and reacting with other molecules 
(Murphy, 2009). However, S. cerevisiae, when grown on glucose (or any 
fermentable sugar) as a carbon source, grows preferentially by fermentation, 
thereby shutting off respiration and producing ethanol which is excreted outside of 
the cell. When glucose is no longer available, S. cerevisiae switches to respiration 
and oxidizes the remaining non-fermentable carbon source. The process of 
switching to respiration is accompanied by a major change in transcription and 
slowing down of growth rate and it is referred to as a diauxic shift. (Figure 6-2) 
(Zaman et al., 2008). Respiratory metabolism requires the use of the ETC, thus 
more ROS are produced, but also more oxidative stress responses are upregulated 
to neutralize the effect of these ROS. 
 
Detoxification of ROS 
   Detoxification of ROS is mainly accomplished enzymatically via detoxifying 
enzymes. The major ROS detoxifying enzymes are superoxide dismutases  
 (SODs), catalases, and peroxidases (Herrero et al., 2008). These enzymes are 
upregulated upon oxidative stress to detoxify the produced ROS. 
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Figure 6-2. Depiction of the two growth phases of S. cerevisiae when using glucose 
as carbon source.  During the first phase (yellow shaded area) S. cerevisiae grows by 
fermenting the glucose in the medium and excreting ethanol. As glucose is used up a 
metabolic change, referred to as the diauxic shift occurs. Growth rate slows and S. 
cerevisiae reorganizes it metabolism to utilize the ethanol in the medium by respiration 
(pink shaded area).   
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Oxidative damage repair 
   Oxidative stress causes damage in virtually all cellular molecules, including DNA, 
RNA, proteins, and lipids. Sulfhydryl groups of proteins are especially vulnerable to 
oxidative damage. S. cerevisiae has two major systems to repair protein damage 
from oxidation, the thioredoxin (TRX) and the glutaredoxin (GRX) systems, as well 
as other reductases.  Both the TRX and the GRX systems use small molecules 
which contain cysteine. When a protein is oxidized, the thioredoxins or the 
glutaredoxins reduce it by oxidizing their own cysteines.  Both systems are 
complemented by reductases which in turn reduce the thioredoxins or the 
glutaredoxins to recycle them (Grant, 2001). 
 
Regulation of oxidative stress response 
   Oxidative stress responses are regulated at the transcriptional level by the 
transcription factors Yap1 and Skn7 (Brown et al., 1993; Hirata et al., 1994; Krems 
et al., 1996). Yap1 is involved in transcriptional control of all thioredoxin and 
glutathione dependent system as well as the pentose phosphate pathway (PPP). 
The PPP’s activation is needed in order to provide reducing equivalents for both 
systems. Skn7 is only required for activation of some but not all proteins of the TRX 
system. 
 
   Chapter 5 showed that iron response is activated indirectly in the rrp44-exo- 
mutant. Experiments presented in this chapter were conducted to investigate the 
cause of this activation.  Data presented in this chapter shows that ROS levels are 
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elevated in rrp44-exo- mutant and that the ROS elevation is functionally related to 
iron response activation.  Further, I show that the exoribonuclease  mutation causes 
aberrant glucose fermentation. 
 
    
  
 
 
 
131 
 
RESULTS 
The exonuclease is required for protection from hydrogen peroxide induced 
oxidative stress 
   As excess iron can lead to increased production of ROS, the sensitivity of the 
rrp44-exo- mutant to oxidative stress was tested. rrp44-exo-  was grown both in 
liquid YPD medium supplemented with 2hydrogen peroxide (H2O2; Figure 6-3 
A) or on solid  YPD medium (Figure 6-3B) supplemented with 2H2O2. In both 
cases the rrp44-exo- mutant did not grow while the wild-type control grew, indicating 
that rrp44-exo- is hypersensitive to oxidative stress.  
   To test if the sensitivity was specific to hydrogen peroxide or if other oxidative 
stressor could cause similar sensitivity, rrp44-exo- was grown on medium 
supplemented with 50menadione which is another oxidative stress agent. The 
difference between menadione and H2O2 is that menadione does not cause an 
increase of H2O2 but an increase of superoxide (Goldberg and Stern, 1976). Growth 
on medium with menadione was not affected compared to growth on YPD (Figure 
6-4A) indicating that the hypersensitivity was specific to H2O2.   
   To test if the knockout of the exonuclease caused  sensitivity to other general 
stressors, rrp44-exo- strain was also grown at high temperature, 37oC and low 
temperature, 15oC  (Figure 6-4 B). There was no effect on growth compared to 
growth on YPD at 30oC. These data indicated that rrp44-exo- was not generally 
sensitive to stress. Taken together, I concluded that rrp44-exo- is hypersensitive to 
hydrogen peroxide induced oxidative stress.  
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Figure 6-3. rrp44-exo- is hypersensitive to hydrogen peroxide. A. rrp44-exo- and wild- 
type (WT) S. cerevisiae strain were grown in liquid YPD versus YPD+2H2O2 cultures. 
Dashed lines represent growth in YPD; solid lines represent growth in YPD+2MH2O2. 
Green - wild-type; red - rrp44-exo-. B. Growth assay on wild-type and rrp44-exo- on solid 
medium with and without 2 M H2O2.  
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Figure 6-4. rrp44-exo- is not hypersensitive to menadione or temperature stress. A.  
Plate growth assay of wild-type and rrp44-exo- on YPD+ 50menadione and on YPD. B. 
Growth assay on YPD at the indicated temperatures.  
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The exonuclease mutant has increased intracellular levels of ROS  
 
   Either higher production of ROS or the inability to detoxify normal ROS levels can 
lead to the observed H2O2 hypersensitivity phenotype. To test if rrp44-exo
- has 
increased ROS levels, an ROS detection assay was carried out. Briefly, wild-type 
and rrp44-exo- cells were grown in YPD and in YPD + 1H2O2. Next, H2DCFDA 
(2',7'-dichlorodihydrofluorescein diacetate) reagent was added and fluorescence, 
indirectly indicating ROS levels, was measured in a plate reader (for details of the 
assay see Chapter 2).  During growth in YPD medium rrp44-exo- had 2x elevated 
ROS levels relative to wild-type and in YPD+1H2O2 the rrp44-exo
- had 2.3x 
elevated ROS levels over the wild-type strain (Figure6-5).  
   As mentioned earlier, either increased production or defective detoxification can 
lead to increased levels of ROS. However, the microarray data did not point to any 
enzymes normally involved in ROS detoxification. These data, and the results from 
the ROS detection assay above, suggest that the exonuclease mutant has 
increased production of ROS. 
 
Altered iron response and sensitivity to oxidative stress in the rrp44-exo- 
mutant are functionally connected. 
   Many factors affect if iron response is activated. It is possible that the iron 
response activation in rrp44-exo- is related to the ROS production or it is possible 
that the activated iron response is independent of the ROS production. To test that, 
I added iron to oxidatively stressed cells and monitored growth rate. 
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Figure 6-5. rrp44-exo- has increased ROS levels. Relative ROS levels were measured in 
wild-type( green) and rrp44-exo- ( red) with and without H2O2 treatment as indicated. n=3   
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If growth rate is improved, that would indicate that the iron response and oxidative 
stress are functionally related in rrp4-exo- because it would mean that iron response 
itself is not misregulated, but it rather a consequence of oxidative stress. If however 
there was increased sensitivity or no change, then this would indicate that these two 
processes are affected by the exonuclease independently of each other.  
   Wild-type and rrp44-exo- cells were stressed with 1H2O2 for one hour and 
then 100Ferrous Ammonium Sulfate (FAS) was added to the medium as a 
source of Fe3+. Figure 6-6A shows that addition of FAS improved the growth rate of 
rrp44-exo- but did not affect the wild-type strain. This improvement in growth was 
specific to oxidatively stressed cells as addition of FAS to cells grown in YPD 
without H2O2 did not have any effect on growth rate (Figure 6-6B).  
   Growth on solid medium supplemented with 1000x Fe and with low iron was not 
affected in rrp44-exo- compared to growth on SC (Figure 6-6C). In this case SC 
medium was chosen over YPD because SC medium has defined amounts of 
nutrient including iron, therefore making it possible for exact iron calculations to be 
conducted for the 1000x medium.  
   To further support the hypothesis the rrp44-exo- has higher requirements for iron, 
instead of a misregulated iron response, a Northern blot was conducted with a 
probe against FIT2. Both wild type and rrp44-exo- were grown either on YPD, or on 
increasing concentrations of H2O2 – 0.5 M H2O2 and 1.0 M H2O2. As shown 
earlier, rrp44-exo- upregulates the iron regulon without additional oxidative stress. 
However both wild type and rrp44-exo- upregulate iron response upon oxidative 
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Figure 6-6. Iron response and oxidative stress are functionally related in rrp44-exo-.  
A Growth of wild type and rrp44-exo- in YPD stressed with H2O2 for one hour (dashed lines) 
or stressed with H2O2 for one hour followed by supplementation by 100Fe (solid lines). 
B. Growth  of wild-type and rrp44-exo- - in YPD (dashed lines) or  YPD+ 100Fe (solid 
lines). C. Growth assay of wild type and rrp44-exo- on synthetic complete (SC) medium with 
addition of 1000xFe or without iron.  
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stress indicating the upregulation of iron response is a normal physiological 
response of the cells during stress with H2O2 (Figure 6-7).  
 
The exonuclease of the exosome affects the cellular growth during 
fermentative conditions, but not during respiratory conditions   
   In wild-type cells, oxidative stress is produced mostly during respiration. However 
S. cerevisiae grown in log phase on YPD medium grows by fermentation until all of 
the glucose is used up and then it switches to respiration, during which it uses up 
the ethanol that has been excreted in the medium during the fermentative growth 
phase (Zaman et al., 2008). To compare growth rates during respiratory conditions, 
wild-type strain and rrp44-exo- mutant were grown in YEP + 2% glycerol medium. 
This medium has glycerol instead of glucose as a sole carbon source. Since 
glycerol in a non-fermentable carbon source, growth on this medium forces S. 
cerevisiae to grow by respiration. Interestingly, during respiratory growth on YEP+ 
glycerol, wild-type cells and rrp44-exo- growth was the same (Figure 6-8A). The 
results were specific to respiratory growth, not only to glycerol, because wild-type 
and rrp44-exo- grew with the same phenotype on medium supplemented with 
ethanol (YEP+ 2% ethanol) also. The similar growth rates were also confirmed with 
growth in liquid YEP+ glycerol medium (Figure 6-8B). Based on the above data I 
concluded that rrp44-exo- affects only fermentative growth rate but not the 
respiratory growth. 
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Figure 6-7. Activation of iron response after oxidative stress. Northern blots probed for 
FIT2 of wild-type and rrp44-exo- treated with increasing amounts of H2O2, as indicated.   
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Figure 6-8. rrp44-exo- does not have severe growth defect compared to wild-type 
during respiratory growth. A. Wild type and rrp44-exo- growth assay on YEP medium 
supplemented with 2% glucose, 2% glycerol, or 2% ethanol. B. Growth assay of wild type 
and rrp44-exo- in liquid YEP+ glycerol medium.   
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Slow growth phenotype of rrp44-exo- correlates with increased ROS levels 
  If the increased ROS causes the slow growth phenotype, then it is expected that 
there will be no increase in ROS compared to wild type under conditions when the 
rrp44-exo- grows with the same rate as wild type. The only such known condition is 
respiratory growth. To check the ROS levels during respiratory growth, the ROS 
detection assay with H2DCFDA was repeated after growing the cells in YEP + 
glycerol. The ROS levels in wild-type and rrp44-exo- cells had no significant 
difference (Figure 6-9). This indicated that ROS increase is a possible explanation 
for the slow growth phenotype of the rrp44-exo- mutant. 
 
RNA processing and degradation defects of rrp44-exo- are independent of its 
slow growth phenotype and do not correlate with increase of ROS 
   Another possible explanation of the slow-growth phenotype is that it is caused by 
defects in processing and degradation of stable RNAs such as rRNA and snRNA 
that are known substrates for the exonuclease. To test if the defects in the 
transcripts were still present during respiratory growth, Northern blots were done 
with RNA isolated from cells grown in YEP + glycerol and probes against 5.8S 
rRNA, 5’ETS, and U4 snRNA. None of the defects present in YPD growth 
disappeared upon growth in YEP + glycerol (Figure 6-10). These data indicate that 
processing and degradation defects of rrp44-exo- are independent of its slow growth 
phenotype and does not correlate with increase of ROS. 
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Figure 6-9. During respiratory growth rrp44-exo- and wild type have the same ROS 
levels. Relative ROS levels were measured in wild type (green) and rrp44-exo- (red) grown 
in YEP+ 2% glycerol medium.   
 
 
 
143 
 
 
A                                            B                                           C 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6-10. Processing and degradation defects of rrp44-exo- are independent of its 
slow growth. Northern blot analyses of wild type and rrp44-exo- grown either by 
fermentation (glucose) or respiration (glycerol). The blots were probed for A. 5.8S rRNA B. 
5’ETS, and C. U4 snRNA. 
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rrp44-exo- causes aberrant glucose metabolism 
   The fact that rrp44-exo- grows at a different rate compared to wild type during 
respiratory and fermentative conditions suggests that there is an aberrancy 
occurring during fermentative growth. One possibility is that rrp44-exo-   prematurely 
activates the ETC, going into respiration before all of the glucose is used up. 
Another possibility is that rrp44-exo- produces different metabolites during glucose 
fermentation than the wild type.  
   To test if the ETC was prematurely activated, Northern blots with probes against 
components of the bc1 complex (complex III) were conducted. The bc1 complex 
has also been postulated to be the site of most oxidative stress production (Drose 
and Brandt, 2008). None of the components of the bc1 complex were upregulated 
(Figure 6-11) and one, Rip1, which is an iron sulfur protein, had lower levels, both in 
fermentative (with glucose as a carbon source) and respiratory (with glycerol as a 
carbon source) conditions. This indicates that the rrp44-exo- does not upregulate 
ETC genes. 
   To further test if there is aberrancy with the glucose metabolism, the glucose 
intake, the ethanol output, and growth were measured over twenty four hour period 
of growth in YPD. Both wild-type cells and rrp44-exo- used the same amount of 
glucose when corrected for growth rate, however rrp44-exo- had lower ethanol 
output (Figure 6-12). Glucose metabolism in S. cerevisiae produces ethanol, but it  
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Figure 6-11. Levels of ETC transcripts are not upregulated in rrp44-exo-. Northern blot 
analyses of wild type and rrp44-exo- grown either by fermentation (glucose) or respiration 
(glycerol). The probe is indicated on the right of each blot. Relative levels compared to SRP 
are shown below each blot.  
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Figure 6-12. Glucose metabolism is aberrant in rrp44-exo-. Wild-type and rrp44-exo- 
were grown in YPD over 24hr period in triplicates. A. Percentage of glucose in the medium. 
B. Percentage of ethanol in the medium. C. pH of the medium in which wild type and rrp44-
exo- strains were grown was measured at the indicated OD600,  
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also produces lactic acid and acetic acid. The production of lactic or acetic acid will 
lower the pH of the medium. To test if either of these two metabolites may be 
produced, the pH of the medium was measured. Interestingly, it was found that the 
pH of the rrp44-exo- is 2 points lower, at 5, than the starting pH of 7 indicating 
acidification of the medium. While the medium of the wild type strain i salso initially 
acidified, it is recovered and goes back to neutral pH=7 again during the respiratory 
growth. All of the above data indicate that glucose metabolism is aberrant in rrp44-
exo- with lower production of ethanol and higher production of acidic metabolites, 
possibly lactate, acetate, or both.  
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DISCUSSION 
   The data presented in this chapter show the physiological importance of the 
exonuclease of Rrp44 during major cellular processes such as generation of 
oxidative stress and glucose metabolism.  
   The fact that addition of iron to oxidatively stressed cells improves the growth rate 
in the rrp44-exo- mutant, shows that the observed activation of iron response is not 
in fact a misregulation of the iron response itself. Instead, the iron response 
activation is a physiological consequence of another currently unknown aberrancy 
resulting from the lack of the exonuclease activity.  Increase of ROS causes 
upregulation of iron response and the hypersensitivity phenotype is only observed 
during a condition under which the exonuclease mutant has higher ROS levels than 
wild-type cells.  
   Since initially the reason for examining ROS sensitivity was the possibility of too 
much iron causing increase in ROS, it seems counterintuitive that the opposite 
would also be true and too much ROS would cause increase in iron response. 
However, it should be considered that  iron can exist in two different forms in the 
cell – free iron or bound iron and this could make a difference in the way oxidative 
stress and iron response could be related. Iron is rarely found in free form. It is 
usually sequestered in the vacuole or it is bound as a part of a protein prosthetic 
group. Too much free iron would cause oxidative stress and would be resulting in 
lowering of iron import and activating vacuolar sequestration of iron. However, too 
much oxidative stress also damages the bound iron, resulting in increased needs 
for iron due to damage in iron-sulfur clusters (Imlay, 2003). Therefore simply looking 
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at the fact that iron response is activated and having shown that it is related to 
oxidative stress rather than misregulated, it can reasonably be suggested that it is 
the bound iron that is affected  and not that the cell has too much free iron. That 
conclusion is supported by the fact that only the iron sulfur protein in the bc1 
complex of the ETC was affected and it had a lower than wild-type level. 
Additionally, no vacuolar genes related to iron storage were affected in the 
exonuclease mutant, further supporting this hypothesis because the vacuole is the 
site for iron storage in S. cerevisiae. 
   I have established that the increased ROS is related to the iron activation. The 
next question that needs to be answered is what causes the increased ROS in the 
rrp44-exo- mutant, if it is not activation of the ETC. A major possibility is that the 
aberrant glucose metabolism itself causes the ROS generation. Since the rrp44-
exo- strain had less ethanol, and had lowered pH in the medium, it was concluded 
that either lactic acid or acetic acid production maybe increased in this mutant. Both 
lactic acid and acetic acid are known to induce oxidative stress in S. cerevisiae 
(Abbott et al., 2009; Semchyshyn et al., 2011). Furthermore lactate is known to 
react with ferric ion to form a complex which then, via the Fenton reaction, reacts 
with H2O2 to enhance the OH production (Ali et al., 2000). Finally, a microarray 
examining the role of acid stress on gene expression, found that iron response 
genes, regulated by Aft1, were upregulated upon stress with either lactic acid or 
acetic acid (Kawahata et al., 2006). Therefore it is possible that altered glucose 
metabolism, resulting in higher production of either lactic or acetic acid, is the 
reason for the increase of ROS and iron response in the rrp44-exo- strain.   
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   The pH of the medium, however, was lower even after the diauxic shift, yet ROS 
production was at wild-type levels. An explanation of this phenomenon could be that 
after the diauxic shift, enzymes that detoxify ROS are upregulated and lower the 
ROS levels. In fact it has been shown that overexpression of catalase reduced 
oxidative stress induced by lactic acid (Abbott et al., 2009). 
   It would be interesting if in fact all of the physiological responses examined in this 
and the previous chapter stem from the aberrant fermentation that the rrp44-exo- 
carries out. Further experiments to distinguish the exact type and ratio of 
fermentative processes that are carried out will help further narrow down what 
exactly is affected in the pathway, Regardless of the results, the fact that RNA 
metabolism affects glucose metabolism is intriguing by itself and finding the exact 
regulatory RNA will be very exciting. 
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Chapter 7: Conclusions and perspective 
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   The RNA exosome is a major exoribonuclease in eukaryotes and archaea, which 
also has endonuclease activity in eukaryotes. The work presented in this 
dissertation examines some important aspects of the RNA metabolism by the 
exosome. First, I have begun characterizing the cap proteins of the RNA exosome. 
These proteins, Rrp4, Rrp40, and Csl4, because of their location at the entry site of 
the substrate, are possibly important in stabilizing the substrate and/or providing 
specificity to the exosome. Specificity may be provided either directly by binding to 
particular RNAs or indirectly, by interacting with other exosome co-factors or RNA 
bound proteins which in turn provide specificity. Second, I have examined the 
physiological relevance of the exonuclease for cellular processes. Therefore, both 
of these aspects of my research, the characterization of the structure/function 
relationships of the proteins at the site of RNA entry and the physiological effect of 
the exosome, will serve as important basis for future research into the role of the 
exosome.  
  
CONCLUSIONS AND FUTURE DIRECTIONS IN THE STUDY OF THE EXOSOME 
CAP PROTEINS 
 
Rrp4 and Rrp40 have a structural role in the exosome 
  Rrp4 and Rrp40 are essential proteins and, as presented in Chapter 3, all of their 
three domains need to be expressed for viability. As similar as these two proteins 
are structurally, I have shown that they each have unique functions that cannot be 
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substituted by the other one. Additionally, chimeras of the two proteins do not 
substitute for each other indicating that the precise location of the proteins, not only 
their close proximity to the exosome entrance site, is important. Finally, in cis 
expression of Rrp4 domains also does not substitute for the essential role of Rrp4. 
All of these data strongly suggest that Rrp4 and Rrp40 have a structural role in the 
assembly of the exosome complex. Interestingly, an in vitro study showed assembly 
of the exosome with any two of the cap proteins, and also an exosome with only 
Rrp40 (Malet et al., 2010). The Malet et al. study implies that only Rrp40 is 
absolutely required for a stable assembly of the exosome which contradicts the data 
shown in Chapter 3 that suggests that Rrp4 also has a role in bridging PH subunits. 
However it is possible that if the exosome exists in more than one conformation, 
Rrp4 may be needed for only one. Such a scenario may be missed by in vitro 
studies, because confirmations may be driven be specific biochemical or genetic 
factors that are not available in the context of the in vitro studies. In fact, such a 
scenario may be missed also in the context of in vivo studies as they are usually 
carried out under specific standard conditions that do not vary.  As I have shown in 
Chapter 6, the exonuclease mutant has different growth phenotype, ROS amount, 
and iron response activation depending on the carbon source. These differences 
were missed in traditional studies done with glucose and during logarithmic growth 
phase. A comprehensive study, compiling data from various exosome studies, has 
pointed out that published TAP-tagged purifications of the exosome differ in the 
composition of the proteins that elute with one or another exosome subunit 
suggesting that there may be different exosome complexes (Kiss et al., 2012). It is 
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also known that at least in archaea, the exosome exists in different confirmations, 
specifically of the cap proteins including homotrimers of either Rrp4 or Csl4, and 
heterotrimer composed of both Rrp4 and Csl4  (Lorentzen et al., 2007; Roppelt et 
al., 2010; Witharana et al., 2012). Therefore it is possible that a confirmation of the 
exosome, driven by some other, unknown conditions, does in fact require Rrp4 for 
its structural integrity. 
   In addition, at least for Rrp4, my data imply that it has a functional role outside of 
the exosome complex. This role is currently unknown and I have suggested 
experiments (see below) to address this proposed role. It is also possible that Rrp4 
has a non-essential role, given the fact that it is post-translationally modified by 
phosphorylation, but this phosphorylation is not required for viability. The most likely 
possibility is that this phosphorylation has a regulatory role. To determine a possible 
role for the phosphorylation, I have suggested a series of experiments designed to 
comprehensively look at the effects of the potential regulation by the 
phosphorylation. 
 
Csl4 does not stabilize the exosome by bridging PH ring proteins 
   Unlike Rrp4 and Rrp40, I have determined that the third cap protein Csl4 does not 
have role in bridging subunits of the PH ring of the exosome, thus it follows that it 
has only a functional role. Therefore the essential role of Csl4 may be to bind RNA 
or protein cofactors. At this time either of these possibilities is likely.   
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   Whether the proposed RNA or protein binding takes place initially at the entrance 
site of the exosome central channel is debatable. Based on the research I have 
presented in this work, I cannot currently rule out that RNA or proteins are bound by 
Csl4 away from the exosome complex. The fact that viable Csl4 truncations lose 
most of their interactions with the exosome suggests that stable interactions are not 
required for viability. Further experiments need to address this possibility by 
repeating the experiment in a strain in which CSL4 is deleted and the truncations 
are the only Csl4 available in these cells, as described in the conclusion section of 
Chapter 4.  
   Following are several experimental approaches that will help answer important 
questions regarding the cap proteins of the exosome. First, what are the roles of the 
individual domains of the cap proteins? Second, what are the functions of the cap 
proteins? Third, what, if any, are the roles of the cap proteins exclusive of the 
exosome complex?  And finally, what are the roles of the phosphorylation of Rrp4 
and Csl4? 
 
Future directions: Determining the roles of individual domains of the cap 
proteins 
   To determine the role of specific domain interactions, the TAP tagged truncations 
of the individual Rrp4, Rrp40, and Csl4 protein can be used. Briefly, plasmids with 
truncations and full length Rrp4, Rrp40, and Csl4 sequences would be transformed 
individually into a wild-type S. cerevisiae strain. After growth to log phase cells will 
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be harvested, and total protein will be isolated. The total proteins will be run through 
a IgG sepharose column to pull-down the TAP-tagged protein along with any protein 
binding partners. The bound fraction will then be analyzed by mass spectroscopy to 
identify all the binding partners.  Comparing of the mass spectroscopy data of the 
binding partners of the full-length protein and the truncation will indicate which 
proteins (if any) are missing from the fractions bound to truncations.  To determine if 
a domain does in fact interact with a given protein, the individual domain and its 
proposed protein binding partner should be expressed and purified from E. coli and 
in vitro binding assay should be carried out to confirm that the proposed interaction 
is only with that domain and it is direct. In addition to the technical challenges, one 
caveat of this experiment is that if the role of a domain is to bind RNA, this will be 
missed because this approach only tests for protein-protein interaction. If no change 
in protein-protein interaction is discovered, a possibility that this particular domain 
binds RNA should be considered. However, a role of a domain may be to both 
interact with proteins and RNA at different surfaces, therefore the interpretation of 
the results should be carefully done, to avoid overreaching conclusions should a 
binding partner for a domain is discovered. To avoid such errors, an assay for RNA 
binding can also be done. Since the cap proteins are believed to bind RNA non-
specifically, the use of complicated assays such as RIP-seq (RNA 
immunoprecipitation followed by high-throughput sequencing) may not be warranted 
as the amount of data from these high throughput assays may be overwhelming to 
allow for straightforward interpretation. In-vitro assays for exosome activity have 
been done with generic RNA substrates, thus such substrates can be used in gel-
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shift assays together with the various Rrp4, Rrp40, and Csl4 truncations.  Thus, 
both of these experiments, the truncation pull-down and the RNA binding assay 
should add to the characterization of the roles of the individual domains of the cap 
proteins. One exception will be the RPL27-like domain and the S1 domains of 
Rrp40. For these two domains individual distinction will not be possible using this 
method as they are not expressed individually, but a point mutagenesis approach 
may be more suitable.  
 
Future directions: Determining the functions of the cap proteins 
   I have shown that the cap proteins have a functional role. However what that 
functional role is not clear. It is possible that the functional role is the same as for 
the exosome complex, or there is a possibility that individual proteins contribute to 
different functional roles. To determine the functional role of the cap proteins, 
microarray analyses with poly(A) RNA can be completed. Because each of these 
proteins is an essential protein, they cannot be deleted. However they can be at 
least temporary depleted. One widely used method, and one that has also been 
used with the exosome proteins  is depletion by the use of the GAL promoter 
(Allmang et al., 1999a). However, in Chapter 6 of this dissertation I have shown that 
glucose metabolism is affected in the exosome mutant. I have not specifically 
examined growth on galactose, but given the aberrancies seen when glucose is 
used as a carbon source, it is my opinion that a sugar regulated promoter should be 
avoided when completing experiments involving the exosome. The best option 
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would be to use a promoter, such as tetracycline regulatable promoters that are 
independent of sugar type and availability and are also commercially available (Gari 
et al., 1997).  
   To look at the role of the cap proteins the Tet-off system can be used with the 
wild-type TAP-tagged sequence of Rrp4, Rrp40, or Csl4 and transformed into the 
corresponding deletion strain. The depletion, after tetracycline addition, will be 
monitored by a Western blot with antibody against the TAP tag and simultaneously 
cells would be harvested, and total RNA will be extracted to be used for microarray 
analysis.  
   Several conclusions can be drawn for such data, depending on the final results. 
First, the microarray results of cap protein depletion may show completely 
overlapping results with the microarray results of the rrp44-exo- presented in this 
dissertation. Such results, even though unlikely, would suggest that both the cap 
protein and Rrp44’s functional roles are as a part of the exosome complex. Second, 
the microarray results of cap protein depletion may have some, but not all 
overlapping results with the microarray results from the rrp44-exo- and not have 
additional RNA changes. Such results will also suggest that the cap protein’s 
functional role is as a part of the exosome complex, because a role outside of the 
exosome complex would involve different, not overlapping substrates. Third, in 
addition to overlapping results, the cap protein depletion microarray may present 
additional changes in RNA not detected in the rrp44-exo- microarray, which would 
suggest that the particular cap protein has a role outside of the exosome complex. 
Fourth, because the exosome proteins are essential, depletion of one of them may 
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lead to changes not directly associated with the exosome, but provoked by other 
mechanisms related to the cell dying and this should be kept in mind while 
investigating the results from the microarray. 
 
Future directions: Determining the cap proteins roles outside of the exosome 
complex 
   Several lines of evidence suggest that the cap proteins may have roles outside of 
the exosome. First, cap proteins have been visualized in distinct cellular foci 
(Graham et al., 2006). Second, I have shown in this dissertation that at least Rrp4 is 
stable out of the exosome complex. This stability assay can be extended to Rrp40 
as well. To examine possible roles outside of the exosome complex, point mutations 
leading to dissociation with the exosome can be created by analyzing the interacting 
surfaces between the cap protein and the exosome subunits of the PH ring. A 
coimmunoprecipitation assay if the mutant proteins with the exosome should be 
done to confirm that the mutants do not bind the exosome. To determine if the 
essential role of the cap protein is outside of the exosome complex, plasmid shuffle 
assay with the mutated cap protein can be used with a strain which has tetracycline-
regulatable wild-type cap protein.  This experiment will be suitable specifically for 
Csl4, since Rrp40 is known to have a structural role, and my data suggest that Rrp4 
also may have a structural role. If the essential role of Csl4 is out of the exosome 
complex, upon depletion with tetracycline, there will be no effect on growth of this 
mutant compared to a mutant in which wild-type Csl4 has been introduced. 
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Alternatively, if the essential role of Csl4 is as a part of the exosome complex, then 
upon depletion of the wild-type Csl4, the growth will slow down and the strain will 
ultimately stop growing.  
   To look for non-essential roles of the cap proteins that are not as a part of the 
exosome complex, TAP-tagged mutants that do not interact with the exosome, as 
described above, can be introduced into wild-type strain of S. cerevisiae and pull-
down assays can be completed followed by mass spectrometry analyses to look for 
interacting proteins. The protein binding profile of these mutants can then be 
compared to mass spectrometry profile of wild-type cap protein to determine which, 
if any, protein interactions are specific to the mutant proteins.   
 
Future directions: Determining the role of posttranslational modifications of 
Rrp4 and Csl4  
   The presence of posttranslational modifications in Rrp4 and Csl4 suggest that 
these two proteins are regulated. I have shown that such regulation is not related to 
the essential function of these proteins, but nevertheless it would be interesting to 
know why these proteins are posttranslationally modified. Posttranslational 
modifications could be used by the cell to regulate protein localization, abundance, 
or interactions with other proteins. To determine what is the role of the 
phosphorylation of Rrp4 and Csl4, the phosphomutants of Rrp4 and Csl4 that I 
created for this work (see Chapters 3 and 4) can be used in variety of assays. First, 
to look for protein binding partners on a global scale, pull-down assays followed by 
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mass spectrometry can be done with these mutants and compared to wild-type. 
Second, to look for changes in gene expression, microarrays can be completed with 
these mutants and compared to wild-type strains. Third, to look for changes in 
abundance, the phosphomutant protein levels can be compared to wild-type 
corresponding protein by Western blots. Forth, to look for localization changes, the 
mutants can be tagged with GFP and their cellular localization can be observed by 
florescent microscopy. Altogether, completing this set of experiments should 
generate data which will determine the role of the posttranslational phosphorylation 
of these two proteins.  
  
 
CONCLUSIONS AND FUTURE DIRECTIONS IN THE STUDY OF THE 
EXONUCLEASE FUNCTIONAL IMPORTANCE 
The exonuclease is the primary activity of the exosome  
   The catalytic subunit of the Rrp44 has two RNase activities. First, it has an 
exonuclease activity and second it has an endonuclease activity. Interestingly, using 
a microarray analysis and an analysis of internally cut RNAs I have not been able to 
identify any substrates for the endonuclease. Yet the endonuclease is able to 
substitute for the essential role of Rrp44, even though a strain having only 
endonuclease activity grows slower. In contrast, a strain having only exonuclease 
activity does not have any apparent growth defect. Together with the data that 
known substrates of the exosome are only affected in exonuclease mutant, this 
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indicates that the exonuclease is the main activity of Rrp44. One explanation of the 
lack of specific substrates coupled with the ability to provide viability would be that 
the endonuclease’s role may be to provide supporting function to the exonuclease. 
For example if the endonuclease cleaves substrates that have stronger secondary 
structures to speed up their degradation, it may not have specific substrates unique 
to it. Rather, in the absence of the exonuclease, the endonuclease would cleave all 
essential substrates and if that slows down the process, may result in the slower 
growth phenotype. Another possibility is that just for the essential substrates the 
exosome has developed a second degradation site, to ensure that they are 
processed and/or degraded.  
 
Future directions: Determining the essential substrates of the exosome 
   The modest effect in gene expression was surprising given the wide range of 
substrates of the exosome. One possibility is that many substrates are affected by 
both activities and knocking only one out does not result in appreciable mRNA 
changes. An experiment that can be carried out in order to determine the effect on 
gene expression of Rrp44 is to attempt to complete a microarray analysis or high-
throughput sequencing using a double mutant rrp44-exo- rrp44-endo-. Briefly, a 
rrp44-exo- rrp44-endo-  strain carrying a Tet-regulatable rrp44-exo- on a plasmid, 
could be grown in liquid YPD medium at OD600=0.6 and then the expression from 
the Tet Promoter will be shut off by addition of Tetracycline to the medium. This will 
result in a complete knock-out of the ribonucleic activities of Rrp44. Such mutant is 
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inviable and will stop growing eventually, however depletion will be possible. The 
duration of the depletion will have to be empirically determined. Cells can then be 
collected, RNA extracted and sent either for microarray hybridization or high-
throughput sequencing. For a control a knockout of only the exonuclease can be 
used. Any RNA the level of which is changed in the double mutant will be 
considered to be resulting from overlapping functions of the exonuclease and the 
endonuclease and will further be investigated. A possible difficulty of this 
experiment is that the time during which both activities will be knocked-out may not 
be sufficient to determine any appreciable changes especially in non-coding stable 
RNAs. mRNAs half-life in S. cerevisiae vary greatly with 91% of the transcripts have 
a half-life between 12 and 29  minutes (Munchel et al., 2011) but stable RNAs 
persist throughout the life of the cell and appreciable depletion could be seen upon 
cell division.  Exosome mutants start accumulating defects in 7S rRNA and 5’ETS 
8hrs after a Tetracycline shut off of the Tet-off promoter, and the experiment was 
carried out for 22 hours (Dziembowski et al., 2007).  
   The results from the experiment with this double mutant will point to why the 
exosome is essential because they will give the changes in gene expression. The 
results from a deep sequencing experiment with this mutant will be more 
complicated to interpret because the exosome affects may different RNAs. 
However, the deep sequencing approach is more useful if the specific substrates of 
the exosome are to be identified.  
   Another approach that can be taken to identify essential roles of the exosome is to 
carry out a genetic complementation screen. A library of S. cerevisiae ORFs can be 
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transformed into an rpp44-exo- rrp44-endo- mutant to screen for loss of synthetic 
lethality. However this approach may only be effective if the synthetic lethality is due 
to one or a few genes. If the synthetic lethality results from a global effect on gene 
expression then this genetic test will not be useful.   
 
Model of how rrp44-exo- affect physiological responses of the cell 
   In chapter 6 I showed that the rrp44-exo- mutant affects glucose metabolism and 
that during glucose growth, rrp44-exo- outputs less ethanol than wild-type strain 
while simultaneously acidifying the medium more than the wild-type strain. The slow 
growth on glucose correlated with higher ROS production. Additionally I showed 
that iron response was activated during oxidative stress and that addition of iron 
improved the growth of an oxidatively stressed rrp44-exo- mutant. Based on 
comprehensive analysis of the above data, I have developed a model of how rrp44-
exo- affects iron response in YPD medium (Figure 7-1). Knowing that lactic acid 
causes oxidative stress, I postulate that the rrp44-exo- mutant produces more  acid 
(either lactic or acetic acid) during glucose metabolism, which in turn leads to the 
production of increased amount of ROS and therefore to activation of iron response 
(Figure 7-1).  Both acetic and lactic acid induce oxidative stress in S. cerevisiae 
(Abbott et al., 2009; Semchyshyn et al., 2011), therefore either one will be capable 
of inducing such physiological response. Additionally, both acetic and lactic acid 
induce iron response genes similarly to the ones induced in the rrp44-exo- mutant 
(Kawahata et al., 2006).  
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Future directions: Testing the model of how the rrp44-exo- mutant affects 
physiological responses of the cell 
   There are several experiments that could be carried out in order to test my model. 
First, there are two possibilities for the lower pH in the medium of rrp44-exo- : one is 
increase in lactic acid; the other is increase in acetic acid. To be able to further 
narrow down what element of glucose metabolism is affected in rrp44-exo- it is 
necessary to determine which one of these acids causes the increased acidity of 
the medium. Kits able to measure either one of these acids are commercially 
available and can be used for that purpose.   To test the possibility that acidification 
causes the slow growth of rrp44-exo- an experiment to neutralize the acid in the 
medium could be carried out. Buffering the medium has been shown to reverse the 
growth impairments caused by lactic acid and acetic acid toxicity in S. cerevisiae 
(Thomas et al., 2002). Wild-type and rrp44-exo- strains could be grown in YPD 
medium which is monitored for pH change and the pH adjusted by KOH and HCl 
addition as needed. Improvement in growth rate as compared to wild-type will 
indicate that the slower growth phenotype is caused by the addition of acid. 
Conversely, no change in growth phenotype will indicate that slower growth is 
independent of acid production.  
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Figure 7-1 A model of how rrp44-exo- affect physiological responses of the cell. Left - 
Wild-type cells during growth with glucose as a carbon source grow preferentially by 
ethanol fermentation, putting out in the medium mostly ethanol and some lactic and acetic 
acid. Right – rrp44-exo- mutant during growth on glucose as a carbon source have lowered 
output of ethanol and increased output of either lactic or acetic acid which leads to increase 
ROS production which in turn leads to activation of the iron response.  
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   Lactic and acetic acid are known to cause an increase in oxidative stress. To test 
if they are the specific cause for the oxidative stress production in rrp44-exo- ,wild-
type and rrp44-exo-  strains could be grown as their `medium is regularly exchanged 
coupled with ROS measurement and northern blots to probe for iron response 
mRNAs. In addition, medium form wild-type and rrp44-exo- mutant can be taken 
and used to supplement a wild-type strain and to measure changes in growth rate, 
ROS production and iron response mRNAs. In addition, an experiment in which 
increasing amounts of lactic acid and/or acetic acid are added to the media could be 
carried out to confirm increase of ROS and iron response activation. Results from 
these experiments will identify if the source of the physiological responses seen in 
rrp44-exo- is an excreted product in the medium from aberrant fermentation. 
 
Final remarks 
   The RNA exosome in a major exoribonuclease involved in numerous cellular 
processes. This dissertation contributes to the understanding of the importance of 
this RNA degrading machinery by first characterizing the roles of the three cap 
proteins in the exosome and second by beginning to elucidate the physiological 
importance of the exonuclease of the exosome. Lastly, this work provides a testable 
model to serve as a foundation for future experiments to elucidate the physiological 
importance of the main catalytic activity of the RNA exosome. 
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